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Abstract 
Mutations of SLC26A4 are the most common cause of the hearing loss associated with 
enlargement of the vestibular aqueduct.  SLC26A4 encodes pendrin, an anion 
exchanger expressed in the cochlea, the vestibular labyrinth, and the endolymphatic 
sac of the inner ear.  Slc26a4Δ/Δ mice, devoid of pendrin expression, develop an 
enlarged membranous labyrinth which leads to the failure to develop hearing, thereby 
recapitulating the human disease.  Identifying the  ionic composition of the endolymph 
and evaluating the importance of pendrin expression at various sites are initial steps 
towards developing strategies for preventing enlargement of the endolymph volume and 
subsequently restoring the inner ear functions.  The major aims of the present study are 
1) To determine the ionic composition of inner ear fluids during the developmental 
phase in which the enlargement of the endolymph volume occurs; 2) To test the 
hypothesis that pendrin expression in the endolymphatic sac is more important than its 
expression in the cochlea and the vestibular labyrinth.  Here, we determined the Na+ 
and K+ concentrations in the cochlea and the endolymphatic sac with double-barreled 
ion-selective electrodes and generated a mouse model that restores pendrin expression 
in the endolymphatic sac while lacking expression in the cochlea and the vestibular 
labyrinth.  High Na+ and low K+ concentrations were found in the cochlear endolymph 
during the embryonic stage.  A rise of the K+ concentration along with a decline of the 
Na+ concentration occurred shortly before birth.  The site-specific restoration of pendrin 
to the endolymphatic sac prevented enlargement and rescued hearing and balance.  In 
conclusion, these data demonstrate that endolymph, in the phase of luminal 
enlargement during the embryonic development, is a Na+-rich fluid that is modified into 
a K+-rich fluid just before birth; restoration of pendrin in the endolymphatic sac is 
sufficient for developing normal inner ear function.  Furthermore, these data suggest 
enlargement of endolymph volume caused by the loss of Slc26a4 is a consequence of 
disrupted Na+ absorption.  Moreover, pharmacological strategies that correct fluid 
transport, as well as spatially and temporally limited restorations of pendrin, might 
restore normal inner ear functions in humans carrying mutations of SLC26A4. 
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Abstract 
Mutations of SLC26A4 are the most common cause of the hearing loss associated with 
enlargement of the vestibular aqueduct.  SLC26A4 encodes pendrin, an anion 
exchanger expressed in the cochlea, the vestibular labyrinth, and the endolymphatic 
sac of the inner ear.  Slc26a4Δ/Δ mice, devoid of pendrin expression, develop an 
enlarged membranous labyrinth which leads to the failure to develop hearing, thereby 
recapitulating the human disease.  Identifying the ionic composition of the endolymph 
and evaluating the importance of pendrin expression at various sites are initial steps 
towards developing strategies for preventing enlargement of the endolymph volume and 
subsequently restoring the inner ear functions.  The major aims of the present study are 
1) To determine the ionic composition of inner ear fluids during the developmental 
phase in which the enlargement of the endolymph volume occurs; 2) To test the 
hypothesis that pendrin expression in the endolymphatic sac is more important than its 
expression in the cochlea and the vestibular labyrinth.  Here, we determined the Na+ 
and K+ concentrations in the cochlea and the endolymphatic sac with double-barreled 
ion-selective electrodes and generated a mouse model that restores pendrin expression 
in the endolymphatic sac while lacking expression in the cochlea and the vestibular 
labyrinth.  High Na+ and low K+ concentrations were found in the cochlear endolymph 
during the embryonic stage.  A rise of the K+ concentration along with a decline of the 
Na+ concentration occurred shortly before birth.  The site-specific restoration of pendrin 
to the endolymphatic sac prevented enlargement and rescued hearing and balance.  In 
conclusion, these data demonstrate that endolymph, in the phase of luminal 
enlargement during the embryonic development, is a Na+-rich fluid that is modified into 
a K+-rich fluid just before birth; restoration of pendrin in the endolymphatic sac is 
sufficient for developing normal inner ear function.  Furthermore, these data suggest 
enlargement of endolymph volume caused by the loss of Slc26a4 is a consequence of 
disrupted Na+ absorption.  Moreover, pharmacological strategies that correct fluid 
transport, as well as spatially and temporally limited restorations of pendrin, might 
restore normal inner ear functions in humans carrying mutations of SLC26A4. 
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Chapter 1 Introduction 
Organization of Chapter 1 
This chapter provides an overview of inner ear anatomy, physiology and genetics with 
an emphasis on the hearing and balance function.  It starts with an introductory section 
on the inner ear anatomy, development and physiology, followed by a summary of the 
environmental and genetic factors that cause hearing impairment.  The last section 
focuses on the gene SLC26A41, that when mutated contributes to the hearing loss 
associated with enlarged vestibular aqueduct (EVA).   
Inner ear anatomy  
The mammalian ear is comprised of the three parts: the outer ear, middle ear and inner 
ear (Figure 1.1A).  The outer ear is comprised of the pinna, the external auditory canal 
and the surface of tympanic membrane.  The pinna collects and directs the sound 
through the ear canal to the tympanic membrane.  In some mammals with mobile 
pinnae, each pinna helps to localize the direction of the sound.  In humans, the direction 
of the sound is localized by the central nervous system.  The ear canal is important to 
direct and concentrate the sound wave.  Blockage of the ear canal results in the 
                                            
1 In compliance with the guideline for human gene nomenclature from HUGO gene nomenclature 
committee (http://www.genenames.org/) [1] as well as the guideline for mouse gene nomenclature 
(http://www.informatics.jax.org/mgihome/nomen/) , the symbols for human genes are represented with 
italicized upper-case letters and the symbols for murine genes are represented in italicized letters with 
only the first letter being capitalized.  e.g. KCNQ1 represents the gene in human, and Kcnq1 
represents the gene in mouse.   
The symbols to corresponding proteins are represented as all upper-case letters, but are not italicized 
for either human or mouse.  e.g. KCNQ1 represents the protein expressed in both human and mouse.  
Exception: In Chapter 1, instead of using SLC26A4 as the symbols for encoded protein, pendrin 
represents the encoded proteins in both human and mouse. 
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The middle ear, also known as tympanic cavity, is an air-filled cavity behind the 
tympanic membrane that is connected to the oral cavity through the Eustachian tube.  
The Eustachian tube is normally closed but briefly opens during swallowing, which 
equalizes the pressure between the tympanic cavity and the atmosphere.  The middle 
ear contains three ossicles, malleus, incus and stapes, that connect the tympanic 
membrane to the oval window of the cochlea.  Sound, which consists of periodic air-
pressure variations, induces movements of the tympanic membrane, which in turn 
induce a “chain-movement” of the three ossicles.  The last of the three ossicles, the 
stapes, contacts the oval window and transmits the movements to the inner ear fluids.   
The inner ear, resides in the temporal bone.  It houses the membranous labyrinth, which 
consists of two epithelia-lined fluid compartments (Figure 1.1B).  One compartment 
consists of the cochlea for detecting sound, the saccule for detecting linear acceleration, 
and the endolymphatic sac, a non-sensory structure believed to be involved in fluid 
regulation [5].   The other compartment consists of the utricle for detecting linear 
acceleration and three ampullae with semicircular canals for detecting angular 
acceleration.  The lumen of both compartments is filled with endolymph and the two 
epithelial structures are surrounded by perilymph.   Perilymph is essentially a common 
compartment that is defined by the temporal bone.  The epithelia of the membranous 
labyrinth are heterogeneous consisting of sensory cells as well as a variety of 
supporting cells that define the structure, determine the composition of the luminal fluid, 
and set the transepithelial voltage (see section “Inner ear physiology”).  
The two major fluids of the inner ear, endolymph and perilymph, are very different in 
their composition.  Endolymph contains high K+, Cl-, and HCO3- concentrations and low 
Na+ and Ca2+ concentrations, which is an unusual composition for an extracellular body 
fluid [6].  In contrast, perilymph contains high Na+ and Cl- concentrations similar to other 
extracellular fluids in the body.   
The cochlea is a snail-like structure consisting, in humans and mice, of two and half 
turns (Figure 1.1B).  In the cochlea, by sectioning along the cochlear modiolus from the 
apical to the basal turns, four cross-sections of the membranous labyrinth can be 
visualized (Figure 1.1C).  Scala media is the term for the membranous labyrinth in the 
4 
cochlea.  Scala media is surrounded by two open perilymph-filled fluid spaces, scala 
vestibuli and scala tympani.  Scala vestibuli and tympani are connected throughout the 
length of the cochlea via the interstitial fluid of the spiral ligament.  In addition, scala 
vestibuli and scala tympani are connected at the cochlear apex.  This connection is 
termed helicotrema.  In the cochlea, scala media is enclosed by the sensory and non-
sensory epithelia cells (Figure 1.1D).  The sensory epithelia consisting of inner and 
outer hair cells are located in the organ of Corti and the non-sensory epithelia consist of 
a variety of supporting cells that define the cochlear structure, maintain endolymph 
composition and transepithelial voltage (see section “Inner ear physiology”).  
 
Inner ear morphogenesis 
 
Figure 1.2: Embryonic morphogenesis of the murine inner ear. 
ED: Endolymphatic duct.  Artwork by Dr. Philine Wangemann, reproduced from Wangemann 2011 [7].  
 
The knowledge about the development of the inner ear has mainly acquired from the 
study of animal models (see textbook “Development of the Inner Ear” [8] for review).  
For example, the morphology of the inner ear at different developmental stages from the 
formation of the otocyst onward, has been established, by using the paint – filled 
technique, which enables the visualization of the fluid space enclosed by inner ear 
epithelia [9].  The development of the murine inner ear begins with the formation of the 
otic pit at embryonic day (E) 9, which is formed by the invagination of ectodermal cells 
(Figure 1.2).  The continuous bending and eventual closure of the otic pit at E9.5, forms 
5 
a spherical structure, termed otocyst.  The morphogenesis of the inner ear from the 
otocyst, is guided by factors from the adjacent hindbrain and mesenchyme.  This 
process starts at E10 with a protrusion from the dorsal side of the otocyst that forms the 
primordium of the endolymphatic duct and sac system.  At E11, a protrusion from the 
ventral side of the otocyst appears and forms the primordium of the cochlear duct.  In 
the next 6-7 days, the primordia of the endolymphatic duct and sac system, as well as 
the cochlear duct, continue to elongate to achieve their full structures.  
Contemporaneously, the middle portion of the otocyst gradually forms the vestibular 
labyrinth, including the saccule, the utricle, and the semicircular canals [10].  Between 
E16.5 to17.5, the closure of the duct between the saccule and utricle separates the 
membraneous labyrinth into two fluid-compartments with one compartment composed 
of cochlea, saccule and endolymphatic sac and the other one composed of utricle and 
semicircular canals [11].   
 
Inner ear physiology 
The inner ear contains both sensory and non-sensory epithelial cells, which enclose the 
endolymphatic space.  Sensory cells are responsible for transducing mechanic signals 
of sound and acceleration into electric signals - a process termed mechanotransduction.  
Nonsensory cells are essential for supporting this mechanotransduction by maintaining 
the ion composition in endolymph and generating a high endolymphatic potential.  
 
Mechanotransduction 
The sensory hair cells are responsible for detecting the sound in the cochlea (Figure 
1.3A), the linear accelerations in the utricle and saccule (Figure 1.3B), and the angular 
accelerations in the ampullae (Figure 1.3C).  For an overview, refer to the textbook by 
Boron and Boulpaep [12].   
In the cochlea, one row of inner hair cells and three rows of outer hair cells are arranged 
in parallel in a structure termed organ of Corti (Figure 1.3A).  The hair cells on the basal 
turn of the cochlea are responsible for detecting high-frequency sound, while the hair 
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The stereocilia contain mechanosensitive transduction channels (MTCs), which are 
nonselective cation channels of unclear molecular identity [18].  The stereocilia are 
overlaid by extracellular matrices.  In the cochlea, outer hair cells contact the tectorial 
membrane and in the ampullae, vestibular hair cells contact the cupulae (Figure 1.3).  
The tectorial membrane and the cupulae consist of non-mineralized protein matrices.  In 
utricle and saccule, vestibular hair cells are covered by otoconial membranes, which 
consist of a protein matrix embedded with mineralized otoconia that provide inertia.  
Sound and acceleration induce relative movements between the extracellular matrices 
and the stereocilia and cause deflections of the hair bundles.  The deflection of 
stereocilia towards the higher rows opens the MTCs, whereas the deflection of 
stereocilia towards the lower edges closes the MTCs [19].  MTC opening allows the 
influx of cations, primarily K+, which depolarizes the membrane potential.  This 
depolarization triggers the release of neurotransmitters from the basal pole of the hair 
cell into the synaptic cleft which modulates the action potential frequency of contacting 
neurons.  For more detailed information of mechanotransduction, see reviews Holt & 
Corey, 2000 and Schwander et al., 2010 [17,20]. 
 
K+ recycling 
K+ is the main current carrier for mechanotransduction, since K+ is the major cation in 
endolymph.  The high concentration of K+ in cochlear and vestibular endolymph (~150 
mM) originates from marginal cells in the cochlea and from dark cells in the vestibular 
labyrinth [21].  The physiological benefits for K+ as the major current carrier are: 1) K+ is 
the most abundant cytosolic cation, therefore the influx of K+ minimally disturbs 
intracellular ion homeostasis; 2) the influx and extrusion of K+ follow the electrochemical 
gradient, therefore, the mechanotransduction process is energetically inexpensive for 
the sensory cells [22].  
The high K+ concentration in cochlear endolymph originates from marginal cells of stria 
vascularis.  Stria vascularis is a multi-layered sheet of vascularized non-sensory 
epithelial cells in the lateral wall of the cochlea that rest on the spiral ligament, which 
consist of specialized fibrocytes [23].  Stria vascularis is comprised of three cell layers, 
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may be buffered by supporting cells in the organ of Corti and ultimately diffuse via 
perilymph toward the fibrocytes in the spiral ligament.  2) K+ may be taken up into 
supporting cells in the organ of Corti and reach fibrocytes in the spiral ligament through 
a network of gap junctions.  K+ leaves endolymph not only via hair cells but also via 
non-sensory epithelial cells, including those of the outer sulcus [25,26].  K+ cycling is not 
limited to the cochlea.  In the vestibular labyrinth, K+ cycling consists of K+ secretion in 
vestibular dark cells and K+ efflux via hair cells and transitional cells [4].   
 
Endocochlear potential 
The driving force for mechanotransduction is primarily generated by K+ channels in the 
basolateral membrane that generate a negative membrane potential in cochlear and 
vestibular hair cells.  The endocochlear potential is a transepithelial potential that is 
generated by stria vascularis and that contributes to the driving force for 
mechanotransduction in the cochlea [27,28].  The endocochlear potential is specific to 
the cochlea.   There is no equivalently large positive transepithelial potential in the 
vestibular labyrinth.  To the contrary, the transepithelial potential in the vestibular 
labyrinth is negative [29].  The endocochlear potential depends on a serial arrangement 
of two epithelial barriers that exists in the cochlea but not in the vestibular labyrinth.   
In cochlea, stria vascularis consist two epithelial barriers that are comprised of epithelial 
cells linked by tight junctions [4].  Tight junction-linked marginal cells form the barrier 
that separates intrastrial fluid from endolymph and tight junction-linked basal cells form 
the barrier that separates intrastrial fluid from perilymph (Figure 1.4).  Intermediate cells 
are connected via gap junctions to the inner membrane of basal cells and fibrocytes of 
the spiral ligament are connected via gap junctions to the outer membrane of basal cells.  
The density of gap junctions is extremely high so that the membrane potential across 
the inner membrane of basal cells is defined by the K+ channel KCNJ10 that is located 
in intermediate cells and that the membrane potential across the outer membrane of 
basal cells is defined by the channels that are located in fibrocytes.  The endocochlear 
potential is a K+ diffusion potential that is generated across the K+ channel KCNJ10 
located on intermediate cells [29].  The magnitude of the potential depends on the low 
10 
K+ concentration in the intrastrial fluid and the high K+ concentration in the cytosol of the 
intermediate cells [6].   
 
Pendrin  
Hearing loss associated with enlarged vestibular aqueduct (EVA) 
The association between pendrin and hearing loss associated with EVA has been 
studied extensively and this literature has been reviewed by Ito et al 2011 and Griffith 
and Wangemann 2011 [30,31].  An excerpt assembled from these reviews is presented 
here. 
Mutations of SLC26A4 are a common cause for neurosensory hearing loss with 
enlarged vestibular aqueduct (EVA), which manifest in a non-syndromic and a 
syndromic form.   The non-syndromic form is called DFNB4 (non-syndromic deafness, 
autosomal recessive 4; MIM # 600791) and the syndromic form is called Pendred 
syndrome (MIM #: 274600)[32–35].   Pendred syndrome consists of neurosensory 
hearing loss and deficiency in iodine organification in the thyroid.  The degree of hearing 
loss in humans with DFNB4  or Pendred syndrome is highly variable ranging from mild 
to profound with a manifestation that can be unilateral or bilateral, stable, fluctuating 
and/or progressive in nature [36].   
DFNB4 and Pendred syndrome are autosomal recessive conditions.  If mutations of 
SLC26A4 were the sole causes for DFNB4 or Pendred syndrome, it would be expected 
that carriers of bi-allelic mutations manifest disease and carriers of mono-allelic 
mutations do not manifest disease.  However, in many patients with DFNB4 or Pendred 
syndrome, only one or even no mutant allele of SLC26A4 was found [37].  This finding 
suggests that factors, other than the mutations of SLC26A4 that were detected in 
screens can cause DFNB4 and Pendred syndrome.  Factors may be environmental, 
epigenetic or genetic in nature [37].  For example, common screening methods do not 
cover the complete non-coding regions, including the entire promoter and introns, in 
which mutations could be hidden [38].  Further, genes other than SLC26A4 may be 
responsible or contribute to disease manifestation.  A digenic inheritance pattern has 
11 
been demonstrated in mice where double-heterozygous mouse Foxi1+/- / Slc26a4Δ/+ 
develop neurosensory hearing loss and EVA [39].  Analogous, a digenic inheritance 
pattern has been found in patients with neurosensory hearing loss and EVA, who carry 
mono-allelic mutations of SLC26A4 and mono-allelic mutations of FOXI1 or KCNJ10 
[39,40].  These digenic inheritance patterns, however, have been found only in a few 
families and appear to not represent a prevalent cause of neurosensory hearing loss 
with EVA [41,42].  Other candidates for digenic inheritance patterns are genes, such as 
ATP6V1B1 and ATP6V0A4 that are expressed in mitochondria-rich cells of the 
endolymphatic sac and contribute to ion transport similar to SLC26A4.     
ATP6V1B1 and ATP6V0A4 encode subunits of the vacuolar H+-ATPase.  In humans, bi-
allelic mutations of ATP6V1B1 are associated with early-onset profound neurosensory 
hearing loss and EVA [43–46].  Bi-allelic mutations of ATP6V0A4 are associated with 
late-onset of neurosensory hearing loss with various degrees of severity [43,47].   
Unlike human patients with bi-allelic mutations of ATP6V1B1, mice lacking functional 
expression of ATP6V0B1 develop normal hearing [48], which is due to a compensatory 
mechanism mediated by the ATP6V0B2, the B2 subunit of vacuolar H+-ATPase [49].  
Unlike human patients with bi-allelic mutations of ATP6V0A4, mice lacking functional 
expression of ATP6V0A4 are profound deaf and develop an enlarged endolymphatic 
space and EVA [50–52].   
Based on these studies in humans and animal models, it is plausible to speculate that 
double-heterozygous mouse Atp6v0a4Δ/+ / Slc26a4Δ/+ may develop neurosensory 
hearing loss and EVA and that a digenic inheritance pattern consisting of mono-allelic 
mutations of ATP6V1B1 and mono-allelic mutations of SLC26A4 may exists among 
patients presenting with neurosensory hearing loss and EVA.   
 
Protein structure 
Pendrin, encoded by SLC26A4, belongs to the solute carrier 26A (SLC26A) family, 
which contains 11 members in human [53].  SLC26A1 and SLC26A2 encode sulfate 
transporters.  SLC26A3, SLC26A4 and SLC26A6 encode Cl-/HCO3- exchangers, 
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plasma membrane [54].  Pendrin, and other members in SLC26 family, contain a STAS 
(Sulfate Transporter and Anti-Sigma factor antagonist) domain near their C-terminal 
position.  The STAS domain in pendrin may regulate the interaction with CFTR that 
leads to a stimulation of ion transport [55,56].  Human pendrin contains two predicted 
protein kinase A (PKA) phosphorylation sites, whereas mouse pendrin contains only 
one PKA phosphorylation site.  Phosphorylation sites may be involved in regulating the 
trafficking of pendrin to plasma membrane [57,58] (see “Posttranslational regulation”).  
In addition, human and mouse pendrin contains two predicted N-linked glycosylation 
sites at asparagine (N) 167 and 172.  Glycosylation has been shown to confer pH 
sensitivity upon pendrin [59] (see “Posttranslational regulation“). 
 
Function  
Pendrin is an electroneutral anion exchanger unlike SLC26A3 and SLC26A6, which are 
electrogenic ion exchangers [60,61].  Pendrin was initially thought to transport SO42- 
based on membership in the SLC26A family, which contains the SO42- transporters, 
SLC26A1 and SLC26A2 [33].  However, functional expression studies of pendrin in 
oocytes as well as insect and mammalian cell lines revealed that pendrin does not 
transport SO42-, but other small anions such as Cl- , I- , OH-, CHOO- and HCO3- [62–65].  
Anion transport mediated by pendrin has been investigated in native tissues and cell 
lines from the kidney, thyroid, salivary gland and the airways.  In the cortical collecting 
ducts of the kidney, pendrin mediates HCO3- secretion [66].  In thyroid cells, pendrin 
mediates iodide efflux [67,68,68,69].  In parotic ducts of the salivary gland, pendrin 
mediates I- secretion [70] and in bronchial epithelial cells of the airways, pendrin 
mediates SCN- secretion [71]. 
 
Transcriptional regulation 
The transcriptional regulation of pendrin has been studied extensively and this literature 
has been reviewed by Rozenfeld et al., 2011 [64].  An excerpt assembled from this 
review is presented here. 
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vivo stimulatory effect of aldosterone on pendrin mRNA expression modulates the 
activity of NaCl absorption in kidney and consequently regulates the volume of 
extracellular fluid. 
Uroguanylin response element (URE): the URE is located -1.1 kb to -1.0 kb upstream of 
theSLC26A4 start codon [74].  Heat shock factor 1 has been suggested to function as 
the trans-element of URE [74].  In the kidney, applications of uroguanylin, a natriuretic 
peptide that is mainly secreted by the intestine [75], inhibit pendrin mRNA expression 
[74].  This inhibitory effect of uroguanylin on pendrin mRNA expression increases renal 
natriuresis under the condition of high salt diet. 
Acid-base response element (ABRE): the ABRE is located -1.1kb to -1.0kb upstream of 
the SLC26A4 start codon, which overlaps the URE (Adler et al., 2008 RM_6561).  The 
effect of pH on pendrin mRNA expression is tissue-specific.  In the kidney and inner ear, 
acidic pH inhibits pendrin mRNA expression and basic pH stimulates pendrin 
expression [76,77].  In the liver, acidic pH increases pendrin mRNA expression, 
whereas basic pH does not affect its expression [78].  In the thyroid, pH has no effect on 
pendrin mRNA expression [76].  The regulatory effect of pH on pendrin mRNA 
expression in the kidney and the liver may help maintain the systemic acid-base 
balance [77,79,80].  In the inner ear, the regulatory effect of pH on pendrin mRNA 
expression may help maintain the acid-base balance of inner ear fluids [81]. 
N-GAS motif: the N-GAS motif is the response element for the cytokines IL4 and IL13 
that is located -1.9kb to -1.8kb upstream of the SLC26A4 start codon [82].  IL4 and IL13 
stimulate pendrin mRNA expression in the airways [83–85].  This effect is mediated via 
the JNK/STAT pathway, which activates nuclear translocation and binding of the trans-
element STAT6  to the N-GAS motif [82].  The stimulatory effects of IL4 and IL13 on 
pendrin mRNA expression mediate the innate defense, which may play a role in 
pathologic immune responses seen in asthma and chronic obstructive pulmonary 
disease [71,82].  
FOXI 1 (Forkhead box transcription factor I 1): the cis-element of FOXI1 is located  
-1.9kb to -0.8kb upstream of the SLC26A4 start codon [39,64].  FOXI1 is a master 
transcriptional factor that is expressed in FORE (forkhead related) cells that are present 
16 
in the kidney, the inner ear, and the male reproductive duct  [86,87] [88].  FOXI1 
controls the expression of multiple genes that are involved in pH homeostasis.  These 
genes encode the apically expressed Cl-/HCO3- exchanger pendrin [87], the 
basolaterally expressed Cl-/HCO3- exchangers  SLC4A1 and SLC4A9 [89], multiple 
subunits of the vacuolar H+-ATPase including ATP6V1B1, ATP6V0A1, ATP6V0A4 and 
ATP6V0E2 [90], as well as the carbonic anhydrase CAR2 [88]. 
Thyroid transcription factor 1 (TTF1): the cis-element of TTF1 is located -2.0kb to -1.9kb 
upstream of the SLC26A4 start codon [91].  TTF1 is a master transcriptional factor 
expressed in the thyroid [91,92].  TTF1 controls the expression of genes involved in the 
thyroid hormone synthesis.  These genes encode the thyrotropin receptor [93], the Na+-
I-  symporter SLC5A5 for iodide uptake [94], the Cl-/I- exchanger pendrin for iodide efflux, 
the enzyme thyroid peroxidase for iodide oxidation [95], as well as the protein 
thyroglobulin for iodine organification [96].   
 
Post-translational regulation  
Pendrin can be regulated by post-translational modifications, including phosphorylation 
and glycosylation, that influence plasma membrane abundance and function.  
Furthermore, the activity of pendrin may be modulated through interactions with CFTR. 
PKA phosphorylations associated with the membrane abundance of pendrin.   
Human pendrin is predicted to contain two PKA dependent phosphorylation sites, serine 
49 and threonine 717, which are located in the C- and N-terminal cytosolic regions, 
respectively (Figure 1.5).  Mouse pendrin is predicted to contain only one PKA 
dependent phosphorylation sites, serine 49, which is located in the N-terminal cytosolic 
region.  The phosphorylation and trafficking of pendrin to plasma membrane can be 
regulated via the cAMP/PKA signaling pathway [57,58].  Upon elevated intracellular 
cAMP levels, the phosphorylation of pendrin increased in conjunction with an increased 
membrane abundance.  Mutations of serine 49 and threonine 717 to alanine mitigate 
this response [57,58]. 
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N-glycosylation may confer pH sensitivity upon pendrin   
Acidification of the extracellular pH increases the binding affinity of anions as well as the 
rate of anion exchange in pendrin [59].  This pH sensitivity has been found to depend on 
the predicted N-glycosylation sites at asparagine (N) 167 and 172 (Figure 1.5) based on 
the finding that the pH sensitivity and glycosylation were lost in pendrin with alanine-
substitutions of asparagine 167 and 172 (N167A/N172A).   These substitutions 
abolished pH sensitivity but did not affect surface expression or basal anion exchange 
activity of pendrin.   
Regulation of pendrin activity through the interaction of STAS domain with CFTR.   
Members of the SLC26 family of proteins contain a STAS domain that is comprised of 
two regions in the C-terminal.  In pendrin these span amino acid residues 536-573 and 
654-722 (Figure 1.5).  Studies in SLC26A3 and SLC26A6 demonstrate that the STAS 
domain interacts with the regulatory domain of CFTR and that this interaction stimulates 
the activity of both, the SLC26A member and CFTR [55,97,98].  Evidence for a similar 
interaction between pendrin and CFTR has been provided [55,56].   
 
Physiological role 
Pendrin is expressed in a variety of tissues, including the inner ear, the thyroid gland, 
the kidney, the male and female reproductive system as well as the airways 
[33,71,88,99].  The role of pendrin in the inner ear is essential, as the loss of pendrin 
expression leads to organ failure.  This section focuses on the physiologic role of 
pendrin in the inner ear.  
Location and onset of expression   
In the murine inner ear, pendrin is expressed in the mitochondria-rich cells of the 
endolymphatic sac, the spiral prominence, root cells, and the spindle-shaped cells in the 
cochlea, and the transitional cells in the utricle, saccule and ampullae of the vestibular 
labyrinth (Figure 3.1) [100–102].  Pendrin expression in the inner ear begins in the 
endolymphatic sac at E11.5, in the cochlea at E14.5, and in the utricle, saccule and 
ampullae of the vestibular labyrinth at E16.5 [102].  
18 
Mouse models for hearing loss associated with EVA 
Mutations of pendrin are the most prevalent causes for hearing loss associated with 
EVA.  A number of mouse models in which Slc26a4 expression is genetically modified 
were created and used to elucidate the etiology of this form of hearing loss:   
Slc26a4Δ/Δ mice: Slc26a4Δ/Δ mice bear a deletion of exon 8 of Slc26a4 , which introduce 
a frame-shift [103]. This frame-shift creates a stop codon which can be expected to 
cause a truncation of pendrin after the translation of 347 amino acids, which is ~44% of 
the normal pendrin protein.  Slc26a4Δ/Δ mice lack pendrin expression, fail to develop 
hearing and balance, and develop enlarged endolymphatic compartments and giant 
otoconia.  
Foxi1-/- mice: Foxi1-/- mice bear a complete deletion of the Foxi1 coding sequence [104].  
Foxi1 controls Slc26a4 expression in mitochondria-rich cells of the endolymphatic sac 
but Foxi1 does not affect Slc26a4 expression in the cochlea or the vestibular labyrinth.  
Foxi1 ablation results in the absence of detectable Slc26a4 in endolymphatic sac.  
Foxi1-/- mice are deaf and developed an enlarged endolymphatic space. 
Slc26a4loop/loop mice: Slc26a4loop/loop mice were identified in a screen of mice in which 
mutations were induced by N-ethyl-N-nitroso-urea (ENU) [105,106].  Slc26a4loop/loop 
mice bear a missense mutation (C to T transition), that results in a serine to 
phenylalanine substitution at position 408 (S408F) and in a reduction of ion transport 
activity.  Slc26a4loop/loop mice maintain pendrin expression in the inner ear, however, fail 
to develop hearing and balance, and develop enlarged endolymphatic compartments 
and giant otoconia.   
Slc26a4tm1Dontuh/tm1Dontuh mice: Slc26a4tm1Dontuh/tm1Dontuh mice bear a point-mutation 
(c.919-2A>G) at the splicing site of exon 8 of Slc26a4 [107].  This mutation mimics a 
common mutation observed in Asian populations [108].  In humans, the c.919-2A>G 
mutation reduces the fidelity of splicing leading to the coexistence of correctly splice 
mRNA that contains exon 8 and mRNA that lacks exon 8 [109].  The reduced fidelity of 
splicing is likely leading to a reduced level of protein expression.  
Slc26a4tm1Dontuh/tm1Dontuh mice maintain pendrin expression in the adult cochlea, however, 
pendrin expression levels appear to not be sufficient during the development of the 
19 
inner ear.  Consequently, Slc26a4tm1Dontuh/tm1Dontuh fail to develop hearing and balance, 
and develop enlarged endolymphatic compartments and giant otoconia.   
Slc26a4tm2Dontuh/tm2Dontuh mice: Slc26a4tm2Dontuh/tm2Dontuh mice bear a point-mutation 
(c.2168-A>G) in Slc26a4 that results in a substitution of histidine 723 for arginine 
(H723R) [110].  This mutation mimics a common mutation observed in Asian 
populations [108].  In humans, the H723R mutation leads to a trafficking defect that 
reduces surface expression and eliminates function.  In vitro studies have shown that 
this trafficking defect can be rescued by low temperature or the admission of chemical 
chaperones that restored surface expression and pendrin function [111,112].  Unlike 
humans, mice carrying the H723R mutation develop normal hearing [110].  It is 
conceivable that the H723R mutation in the context of the murine pendrin protein has a 
lesser effect on trafficking so that sufficient levels of pendrin protein are in the inner ear, 
in particular during development.     
Atp6v0a4Δ/Δ mice: Two strains of Atp6v0a4Δ/Δ mice were generated [50,52].  One strain 
bears a deletion of exons 2-4 and the other a deletion of exon 11 of Atp6v0a4.  
Atp6v0a4 encodes a subunit of the H+ ATPase, which is expressed in the cochlea, the 
vestibular labyrinth and the endolymphatic sac of the inner ear.  In the endolymphatic 
sac, Atp6v0a4 is expressed in the apical membrane of mitochondria-rich cells together 
with pendrin [113].  Atp6v0a4Δ/Δ mice fail to develop hearing, develop enlarged 
endolymphatic compartments and lack otoconia [50–52].   
Tg(E);Tg(R);Slc26a4Δ/Δ mice: Pendrin expression in Tg(E);Tg(R);Slc26a4Δ/Δ mice is 
controlled by the bi-transgenic doxycycline-inducible expression system which permits 
control of the time and duration of pendrin expression [114].  This mouse model has 
been used to define the critical time period during which pendrin needs be present for 
the development of a hearing phenotype, see “Pendrin is temporally required for 
hearing acquisition”.   
Tg(+);Slc26a4Δ/Δ mice: Pendrin expression in Tg(+);Slc26a4Δ/Δ mice is limited in the 
inner ear to the endolymphatic sac [115].  This mouse model does not express murine 
pendrin but human pendrin in the endolymphatic sac and lacks the expression of 
pendrin in the cochlea or the vestibular labyrinth.  This mouse model has been used to 
define th
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endocochlear potential, and d) elevation of endolymphatic Ca2+ and loss of hair cells.  
These events are described in the following paragraphs.   
Enlargement of the endolymph volume: A ~10-fold enlargement of endolymph volume 
develops in Slc26a4Δ/Δ mice at E14.5, the time when Slc26a4Δ/+ mice develop a surge in 
Slc26a4 expression in the endolymphatic sac [3].  This enlargement persists throughout 
life [116].  Experiments ablating the endolymphatic sac from cultured otocysts have 
demonstrated that the endolymphatic sac regulates fluid absorption at the early phase 
of cochlear luminal growth [3].  These studies suggest that the enlargement is a 
consequence of a failure to absorb fluid.  Measurements of the endolymphatic Na+ and 
K+ concentrations have revealed that endolymph consists of a NaCl-rich solution during 
the phase of cochlear growth and luminal enlargement [117].  These experiments 
suggest that enlargement of the endolymphatic volume may be a consequence of 
disrupted Na+ absorption by the endolymphatic sac.  The study that contains 
measurements of ion concentrations in embryonic endolymph is presented in Chapter 2.  
The enlargement of endolymph volume stretches the surrounding epithelia and likely 
leads to an increase in diffusional distances for developmental factors, which leads to a 
disruption of inner ear development [116].  Disruption of inner ear development consists 
of events that occur premature or delayed.  For example, Connexin 26, encoded by 
Gjb2, is expressed prematurely in Slc26a4Δ/Δ mice, whereas the development of stria 
vascularis, the organ of Corti, and bone is delayed [102,116].   
Endolymph acidification: Lack of pendrin expression in Slc26a4Δ/Δ mice leads to an 
acidification of endolymph, which is a direct consequence of the loss of pendrin-
mediated HCO3- secretion [81,118].  Acidification begins in the cochlea at E15.5 and in 
the endolymphatic sac at E17.5 [102].  The later onset of endolymph acidification in the 
endolymphatic sac may be due to a stronger buffering capacity of endolymph in the 
endolymphatic sac compared to endolymph in the cochlea.  In addition, it is conceivable 
that lack of pendrin expression reduces surface expression of the H+-ATPase, which 
limits the acid secretion.   
Consequence of the acidification of endolymph include an elevation of the 
endolymphatic Ca2+ concentrations in the cochlea and the vestibular labyrinth [81,118].  
22 
In addition, the acidification may increase activity of the K+ channel Kcnq1/Kcne1 in the 
apical membrane of stria marginal cells [119].   
Loss of the endocochlear potential: Loss of the endolymphatic potential in Slc26a4Δ/Δ 
mice is a consequence of the degeneration of KCNJ10 beginning between P10 and 
P15, which coincides with the onset of  expression of KCNJ10 and the development of a 
mature endocochlear potential [120,121].  Loss of KCNJ10 is due to an elevated level of 
oxidative and nitrative stress in stria vascularis [122].  Oxidative and nitrative stress in 
stria vascularis may be a consequence of delayed development of anti-oxidant defence 
mechanisms or a consequence of higher metabolic rates associated with higher rates of 
K+ secretion.   
Elevation of endolymphatic Ca2+ and loss of hair cells: Loss of hair cells in Slc26a4Δ/Δ 
mice begins at P15, the time at which hearing in Slc26a4Δ/+ mice matures [103].  The 
mechanism that leads to the loss of hair cells is not completely understood.  It is 
conceivable that the elevated endolymphatic Ca2+ concentration leads to a cellular Ca2+ 
overload in the hair cells which triggers apoptosis-mediated cell death [81].   
  
Pendrin is temporally required for hearing acquisition 
Loss of pendrin expression in the inner ear of Slc26a4Δ/Δ mice leads to a severe 
expansion of the endolymphatic space and to a failure to acquire hearing [81,103].  This 
raises the question of whether pendrin is required to maintain hearing throughout life or 
whether pendrin is required only for the acquisition of hearing during development.  The 
latter would define a time-window for a therapeutic intervention.  This question has been 
addressed by investigations that used a model, Tg(E);Tg(R);Slc26a4Δ/Δ mice, in which 
the expression of pendrin could be controlled by a drug administered in the drinking 
water.  Tg(E);Tg(R);Slc26a4Δ/Δ mice are a bi-transgenic model, in which the expression 
of SLC26A4 is controlled by a doxycycline-inducible expression system [114].  Two sets 
of experiments were conducted.  In the first set, the onset of doxycycline administration 
was varied during development.  Induction of pendrin expression at E13.5 but no later 
than E16.5 led to the acquisition of normal hearing.  Induction of pendrin after E16.5 led 
to hearing loss.  In the second set of experiments, doxycycline was present during 
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conception and administration was discontinued at different times of development.  
Discontinuation of pendrin not earlier than P2, yielded normal hearing.  This study 
establishes E16.5 to P2 as a critical period of development during which sufficient 
pendrin expression is required for the acquiring of normal hearing. 
 
Pendrin is spatially required for hearing acquisition 
The restoration of pendrin expression in the inner ear may be the most direct way for 
rescuing the hearing.  Restoration of pendrin expression, however, may not be feasible 
since pendrin is expressed in many different epithelial cells in the inner ear including 
epithelial cells in the cochlea, the vestibular labyrinth and the endolymphatic sac [100–
102].   Mitochondria-rich cells in endolymphatic sac are the first site where the 
expression of pendrin begins in the inner ear [102].  At the time in development at which 
the enlargement begins in Slc26a4Δ/Δ mice, the endolymphatic sac is the only site with 
appreciable pendrin expression in Slc26a4Δ/+ mice [102].  This finding suggested that 
restoring pendrin in the endolymphatic sac would prevent or at least postpone the 
enlargement of endolymph volume.   Consistently, studies in Foxi1-/- mice revealed that 
pendrin expression in the cochlea and the vestibular labyrinth without expression in the 
endolymphatic sac is not sufficient for prevention of enlargement of endolymph volume 
and development of normal hearing [123].  Based on these findings, the hypothesis 
arose that pendrin expression in the endolymphatic sac may be more important than the 
expression in the cochlea or the vestibular labyrinth.  This hypothesis was tested in 
Tg(+);Slc26a4Δ/Δ mice, a transgenic mouse model that expresses pendrin in the 
endolymphatic sac and lacks pendrin expression in the cochlea and the vestibular 
labyrinth [115].  Tg(+);Slc26a4Δ/Δ mice never develop an enlargement of endolymph 
volume and acquire normal hearing and balance function.  These findings suggest that 
a spatial limited expression of pendrin in the endolymphatic sac is sufficient to restore 
normal inner ear function.  The complete study of Tg(+);Slc26a4Δ/Δ mice is presented in 
Chapter 3. 
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Chapter 2 Endolymphatic Na+ and K+ concentrations 
during development 
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Abstract 
Slc26a4Δ/Δ mice are deaf, develop an enlarged membranous labyrinth, and thereby 
largely resemble the human phenotype where mutations of SLC26A4 cause an 
enlarged vestibular aqueduct and sensorineural hearing loss.  The enlargement is likely 
caused by abnormal ion and fluid transport during the time of embryonic development, 
however, neither the mechanisms of ion transport nor the ionic composition of the 
luminal fluid during this time of development are known.  Here we determine the ionic 
composition of inner ear fluids at the time at which the enlargement develops and the 
onset of expression of selected ion transporters.  Concentrations of Na+ and K+ were 
measured with double-barreled ion-selective electrodes in the cochlea and the 
endolymphatic sac of Slc26a4Δ/+, which develop normal hearing, and of Slc26a4Δ/Δ mice, 
which fail to develop hearing.  The expression of specific ion transporters was examined 
by quantitative RT-PCR and immunohistochemistry.  High Na+ (~141 mM) and low K+ 
concentrations (~11 mM) were found at embryonic day (E) 16.5 in cochlear endolymph 
of Slc26a4Δ/+ and Slc26a4Δ/Δ mice.  Shortly before birth the K+ concentration began to 
rise.  Immediately after birth (postnatal day 0), the Na+ and K+ concentrations in 
cochlear endolymph were each ~80 mM.  In Slc26a4Δ/Δ mice, the rise in the K+ 
concentration occurred with a ~3 day delay.  K+ concentrations were also found to be 
low (~15 mM) in the embryonic endolymphatic sac.  The onset of expression of the K+ 
channel KCNQ1 and the Na+/2Cl-/K+ cotransporter SLC12A2 occurred in the cochlea at 
E19.5 in Slc26a4Δ/+ and Slc26a4Δ/Δ mice.  These data demonstrate that endolymph, at 
the time at which the enlargement develops, is a Na+-rich fluid, which transitions into a 
K+-rich fluid before birth.  The data suggest that the endolymphatic enlargement caused 
by a loss of Slc26a4 is a consequence of disrupted Na+ transport.   
(293 words) 
 
Key words: Enlarged vestibular aqueduct; Pendred syndrome; ion-selective electrodes; 
endolymphatic sac; transepithelial potential; endocochlear potential; 
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Introduction 
Enlargement of vestibular aqueduct (EVA) is a common inner ear malformation found in 
children with non-syndromic sensorineural hearing loss and hearing loss associated 
with Pendred syndrome [31].  Mutations of SLC26A4 are a prevalent cause of EVA and 
of progressive and often fluctuating hearing loss with an onset before or around speech 
acquisition [108,124–127].  SLC26A4 codes for pendrin, an anion exchanger that 
functions as a Cl-/HCO3- exchanger in the inner ear [81].  In some populations, 
mutations in SLC26A4 occur in 13-14% of deaf subjects [128,129].   
Slc26a4Δ/Δ mice closely resemble the human phenotype, since Slc26a4Δ/Δ mice acquire 
an enlargement of the vestibular aqueduct during embryonic development.  The 
vestibular aqueduct is a bony tunnel that forms around the epithelia-lined endolymphatic 
duct.  Swelling of the fluid-filled epithelium of inner ear in Slc26a4Δ/Δ mice leads to an 
enlargement of the vestibular aqueduct.  Slc26a4Δ/Δ mice fail to acquire hearing during 
the postnatal phase of development [81,103].  Studies on Slc26a4Δ/Δ mice suggest that 
the endolymphatic enlargement entails a ~10-fold larger luminal volume in the cochlea, 
that the endolymphatic acidification entails a ~2-fold higher H+ ion concentration, and 
that the enlargement and acidification are key events that mark the onset of the 
pathology [102,116].   
The development of the murine inner ear begins with an ectodermal invagination that 
forms an otocyst at embryonic day (E) 9.5.  The otocyst is filled with amniotic fluid, 
which is a NaCl-rich fluid [130].  The otocyst extends two protrusions: one to form scala 
media of the cochlea and the other to form the endolymphatic duct and sac, while the 
middle of the otocyst is reorganized into the vestibular labyrinth [8].  The lumen of the 
endolymphatic sac opens at E10.5 and the lumen of the cochlea begins to open at 
E14.5.  The fluid inside the lumen is called endolymph and the fluid surrounding the 
epithelium is called perilymph.  In Slc26a4Δ/Δ mice, the enlargement of the 
endolymphatic lumen begins at E14.5, which coincides with cochlear growth and lumen 
formation between E14.5 and E18.5 [3,31].   
The mesenchymal tissue surrounding the cochlea, the vestibular labyrinth and the 
endolymphatic duct forms cartilage during embryonic development that is later 
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converted into bone (Figure 2.1A).  In addition, the cochlea and the vestibular labyrinth 
are enclosed in the temporal bone.  Access to scala media of the cochlea is available 
via the round window that is located near the base of the cochlea.  The endolymphatic 
sac is the only part of the inner ear that is not enclosed in cartilage or bone.   
The mechanisms that lead to cochlear enlargement in Slc26a4Δ/Δ mice are not known.  
It is conceivable that fluid accumulation leading to the enlargement occurs in the wake 
of an abnormally low rate of ion absorption or an abnormally high rate of ion secretion.  
Ion transport in the inner ear has so far mainly been studied in adult animals, when 
endolymph consists of a K+-rich fluid [6].  The enlargement of the endolymphatic lumen 
in Slc26a4Δ/Δ mice, however, occurs during embryonic development.  Thus, it is of great 
interest to determine whether endolymph in Slc26a4Δ/Δ and Slc26a4Δ/+ mice at the time 
of enlargement is a K+-rich fluid, as observed in the adult inner ear, or whether 
endolymph at this time is a Na+-rich fluid similar in composition to amniotic fluid.  The 
determination of the ion composition during the phase of enlargement is the very first 
step for understanding how the enlargement occurs.  Thus the main goal of the present 
study was to determine the Na+ and K+ concentrations in cochlear endolymph during 
embryonic development.  
Methods 
Ethics Statement 
All procedures involving animals were approved by the Institutional Animal Care and 
Use Committee at Kansas State University (IACUC#: 2961, 2925 and 3245). 
Animals 
A colony of Slc26a4Δ/+ and Slc26a4Δ/Δ mice was maintained at Kansas State University.  
Slc26a4Δ/+ dams and Slc26a4Δ/Δ sires were housed in monogamous pairs.  Litter sizes 
averaged 4.3 pups with Slc26a4Δ/+ and Slc26a4Δ/Δ offspring in the near Mendelian ratio 
of 50.1 to 49.9.  The average gestational period was 21 days.  Gestational age was 
counted from the day when a vaginal plug was detected.  This day was set to embryonic 
(E) day 0.5 (E0.5).  Pregnancies were verified by ultrasound (Terason t3000, Universal 
Medical Systems, Bedford Hills, NY).   
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Figure 2.1:Experimental configurations.   
Schematic diagrams of the inner ear and of experimental configurations.A) Diagram of the bone-enclosed 
inner ear consisting of the cochlea, the vestibular labyrinth and the endolymphatic duct and sac.  Note, 
that scala media of the cochlea is accessible via the round window and that the endolymphatic sac is the 
only structure not enclosed in bone.  B-E) Experimental configurations for the measurement of voltages 
and of Na+ and K+ concentrations.  Voltage electrodes were used to record the voltage (V) and ion-
selective electrodes, which were filled at the tip with liquid ion exchanger, recorded a signal that consisted 
of the sum of the voltage (V) and the ion-voltage (VK+ or VNa+).  B) Configuration for in situ measurements 
of voltage and K+ concentrations in the cochlea.  C-E) Configuration for in vitro measurements.  Temporal 
bones were isolated and superfused in a bath chamber that was outfitted with an inflow and a suction 
outlet.   C) Configuration for in vitro measurements of voltage and K+ concentrations in the cochlea.  D) 
Configuration for in vitro measurements of voltage and K+ concentrations in the endolymphatic sac.  E) 
Configuration for in vitro measurements of Na+ and K+ concentrations in the cochlea.   
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The colony was maintained free of known and suspected murine pathogens, as 
reported earlier [3].  Slc26a4Δ/+ and Slc26a4Δ/Δ mice ranging in age from E14.5 to P72 
were used in the present study.  Time-pregnant dams were deeply anesthetized with 
4% tri-bromo-ethanol and sacrificed by decapitation after harvesting embryos by sterile 
laparotomy.  Embryos were sacrificed by decapitation.  Neonatal mice (P0) were 
anesthetized by a combination of intraperitoneal (i.p.) injection of 0.014 ml/g body 
weight of 4% tri-bromo-ethanol and rapid cooling on a slush of ice.  Older mice (>P3) 
were anesthetized solely by i.p. injection of 0.014 ml/g body weight of 4% tri-bromo-
ethanol.  Neonatal and older mice were sacrificed by decapitation under deep 
anesthesia. 
 
Measurement of voltage, Na+ and K+ concentrations  
Voltage, Na+ and K+ concentrations were measured with double-barreled ion-selective 
electrodes.  Measurements in prenatal and neonatal mice were carried out using a 
novel in vitro approach.  This novel approach was developed since the well-established 
in situ approach is not suitable for measurements in prenatal mice.  Limitations of the in 
vitro approach were established by comparing results from postnatal mice obtained in 
vitro to data obtained in situ.  
For in situ measurements of K+ concentrations, one barrel of the double-barreled 
electrode was used to measure the K+ concentration and the other barrel was used to 
measure the transepithelial voltage (Figure 2.1B).  Electrodes were manufactured using 
established protocols [29].  Briefly, the K+ selective barrel was silanized prior to being 
filled at the tip with liquid ion exchanger (Ionophore I - cocktail B, Cat# 60398, Sigma-
Aldrich) and backfilled with 1 M KCl solution.  The voltage barrel was filled with 500 mM 
NaCl solution.  Each barrel was connected via a Ag/AgCl electrode to a dual 
electrometer with high input-resistance (FD223, World Precision Instruments, Sarasota, 
FL).     
Mice between ages P62 and P72 were deeply anesthetized and maintained at 37°C 
body temperature using a heated platform.  Surgery consisted of a tracheotomy to 
maintain unobstructed ventilation, the subdermal installation of a flowing 1 M KCl 
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reference electrode in the chest region, and of a ventral approach to the temporal bone, 
using established methods [29].  Briefly, a small opening in the temporal bone was 
made and measurements were obtained by guiding the electrode through the round 
window into the perilymph-filled scala tympani and then into the endolymph-filled scala 
media.  Anoxia was induced by i.p. injection of succinylcholine chloride (1 mg/g body 
weight) after obtaining stable readings of the K+ concentration and the endocochlear 
potential.   
For in vitro measurements of K+ and Na+ concentrations, temporal bones were isolated 
from pre- and postnatal mice and placed into a bath chamber superfused with warm 
(37°C) artificial perilymph (in-line heater SHM-8 and controller TC-344B, Warner 
instruments, Hamden, CT).  Artificial perilymph contained (in mM): 135 NaCl, 25 
NaHCO3, 4 KCl, 1.5 CaCl2, 1 MgCl2 and 5 glucose and was bubbled with a humidified 
gas mixture consisting of 5% CO2 and 95% O2 to set the pH to pH 7.3 - pH 7.4.  The 
bath chamber was grounded via a Ag/AgCl electrode that was bathed in a vial filled with 
1 M KCl solution and connected to the bath chamber via an agar-bridge made from 150 
mM NaCl solution (Figure 2.1C-E).  For measurements in the cochlea, an approach via 
the round-window was used.  For in vitro measurements of K+ concentrations, one 
barrel of the double-barreled electrode was used to measure the K+ concentration and 
the other barrel was used to measure the transepithelial voltage (Figure 2.1C).  For in 
vitro measurement of Na+ concentrations, one barrel of the double-barreled electrode 
was used to measure the Na+ concentration and the other barrel was used to measure 
the K+ concentration as an indicator for successful penetration into the endolymph-filled 
scala media (Figure 2.1E).  This unusual configuration was found necessary, since at 
the ages of interest, the transepithelial voltage was found to be near zero and the Na+ 
concentration in endolymph was found to be similar to the concentration in perilymph, 
such that neither the recording of the voltage nor the recording of the Na+ concentration 
could serve as an indicator for successful penetration into the endolymph-filled scala 
media.   
Dual ion selective electrodes were manufactured using a modified protocol.  Both 
barrels were silanized by a 20 s exposure to silane vapors generated by injecting 10 µl 
di-methyl-di-chloro-silane into a 150 ml beaker sitting on a hot-plate heated to 210 °C.  
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Silanized electrodes were baked for 2 hr at 180 °C.  Tips were broken to an outer 
diameter of 10-12 µm.  The Na+ electrodes were filled at the tip with a calixarene-based 
liquid ion exchanger (Cocktail 2 consisting of (%w/w) 3.5% Na+ ionophore X (Cat# 
71747, Sigma-Aldrich), 95.9% 2-nitrophenyl-octyl-ether (Cat# 73732, Sigma-Aldrich), 
0.6% potassium-tetrakis-(4-chlorophenyl)-borate (Cat# 60591, Sigma-Aldrich) and 
backfilled of 1 M NaCl [131].  Electrodes were stored in 500 mM KCl solution for 2-4 hr 
prior to experiments.   
Calibration of ion selective electrodes in warm (37°C) solutions was performed 
immediately after withdrawal of the electrodes from the temporal bone.  All 
measurements were corrected for calculated liquid junction potentials (JPCalc in 
Clampex, Molecular Devices, Silicon Valley, CA [132]).   
Data were recorded via a flat-bed chart recorder (BD12E, Kipp & Zonen, The 
Netherlands) for easy annotation and also were recorded digitally (Digidata 1322A and 
AxoScope 9, Molecular Devices) for easy analysis using custom software written by 
P.W. (Origin 6.0, The Origin Company, Northhampton, MA).  
Quantitative RT-PCR 
Total RNA was isolated from the cochlea of Slc26a4Δ/+ and Slc26a4Δ/Δ mice between 
E14.5 and P8 (RNeasy micro, Qiagen, Valencia, CA).  Quantity and quality of total RNA 
were evaluated by microfluidic electrophoresis (BioAnalyzer, Agilent, Santa Clara, CA) 
and by microliter absorption photometry (Nanodrop, Wilmington, DE).  RNA samples 
were accepted only when they were free of contamination and when RIN was >7.0, 
which indicates excellent quality.  RIN is a quality indicator on a scale from 0 (worst) to 
10 (best) that is computed from microfluidic electrophoresis runs (BioAnalyzer, Agilent). 
Total RNA, primers, enzymes and buffers necessary for quantitative RT-PCR reactions 
were assembled with the assistance of an automatic pipetting station (Biomek NXP, 
Beckman Coulter, Fullerton, CA) with hardware modifications and software 
programming by P.W.  Reactions were carried out in 96-well plates with each well 
containing ~10 ng of total RNA, gene specific primers, SYBR-green, and an enzyme mix 
containing reverse transcriptase and DNA polymerase (iScript, BioRad, Hercules, CA) 
in a total volume of 25 µl.  Reverse transcription was performed for 10 min at 50 °C and 
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terminated by heating to 95 °C for 5 min (OneStepPlus, Applied Biosystems, Foster City, 
CA).  PCR consisted of 40 cycles of 10 s melting at 95 °C, 30 s annealing and 
elongation at 58 °C, and 15 s fluorescence detection at 78 °C (OneStepPlus, Applied 
Biosystems). 
Gene specific primers were designed using software (Primer 3.0 [133]).  Primer pairs 
spanned introns to discourage amplification of genomic DNA (Table 1).  Amplification of 
a single product of the appropriate size was verified by microfluidic electrophoresis 
(BioAnalyzer, Agilent).   
The number of template molecules (cDNAtemplates) was estimated according to   
         
        t bp size 
threshhold
templates 
C EfficiencyWeightProduct
 Product
cDNA
 ^     mol    g     bp     mol
bp    mol    g     molecules  10    6.02
 molecules  
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  
where 6.02 x 1023 molecules/mol represents Avogadro’s number, Productthreshold is the 
weight of the PCR-product at threshold (0.49 x10-9 g) that was obtained from calibration 
experiments, Productsize is the size of the product in base pairs (bp), Weightbp is 
average weight of one bp (660 g/mol), Efficiency is the PCR-efficiency obtained from 
the slope of the log-linear phase of the growth curve [134] and Ct is the cycle at which 
the fluorescence of the product molecules reaches a common threshold chosen in the 
middle of the log-linear part of the growth curve.   
 
Confocal immunohistochemistry 
Temporal bones were isolated from Slc26a4Δ/+ and Slc26a4Δ/Δ mice and fixed at 4 °C in 
PBS-solution to which 4% paraformaldehyde (Cat# 15714, Electron Microscopy 
Sciences, Hatfield, PA) had been added.  PBS-solution contained (mM): 137 NaCl, 2.7 
KCl, 10.1 Na2HPO4, and 1.8 KH2PO4, pH 7.4.  Fixed tissues were processed through a 
sucrose gradient (10% and 20%, each 30 min, followed by 30% overnight, all solutions 
in PBS at 4 °C), infiltrated with polyethylene glycol (Cat# 72592-B, Electron Microscopy 
Sciences) and cryo-sectioned (12 µm, CM3050S, Leica, Germany).  Mid-modiolar 
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Statistics 
Numerical data were presented as average ± sem with n being the number of replicates.  
Statistical significance was determined based on unpaired t-tests.  Significance was 
assumed at p<0.05.   
 
Results 
Selectivity and sensitivity of K+- and Na+-selective electrodes 
The sensitivity and selectivity of K+ electrodes was evaluated by making recordings in 
solutions containing various concentrations of KCl and NaCl.  Recordings were 
corrected for calculated liquid junction potentials and corrected measurements were 
subjected to a three-dimensional fit to the Nicolski equation: 
            NaA logSVV K10Ki  
where V represents the measured voltage, Vi is an offset term, SK+ is the slope 
representing the sensitivity for K+, [K+] and [Na+] represent the K+ and Na+ 
concentrations, and A is the selectivity coefficient.  K+ electrodes were found to be 
highly sensitive with SK+ near the theoretical value of 60 (52.9 ± 0.5 mV/decade, n=4) 
and highly selective with A close the ideal value of zero (0.028 ± 0.005, n=4).  
Accordingly, steep voltage changes were recorded when the KCl concentration was 
changed in the presence of a constant NaCl concentration of 10 mM and nearly no 
voltage changes were observed when the NaCl concentration was altered at constant 
KCl concentrations of 3, 35 or 68 mM (Figure 2.2A).   
The sensitivity and selectivity of Na+ electrodes was evaluated in a similar fashion using 
solutions containing various concentrations of NaCl and KCl.  Recorded voltages were 
corrected for calculated liquid junction potentials and corrected voltages were subjected 
to a three-dimensional fit to the Nicolski equation:  
              KA Na0.8logSVV 10Nai  
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where SNa+ is the slope representing the sensitivity for Na+ and all other symbols have 
the same meaning as above.  Na+ electrodes were found to be highly sensitive with SNa+ 
near the theoretical value of 60 (57.8 ± 0.9 mV/decade, n=12) and moderately selective 
with A being different from zero (0.13 ± 0.03, n=12).  Accordingly, steep voltage 
changes were recorded when the NaCl concentration was changed at constant KCl 
concentration of 3 or 13 mM and less steep changes were observed when the KCl 
concentration was altered in the presence of a constant NaCl concentration of 10 mM 
(Figure 2.2B).   
 
Simplified calibration procedure for K+-selective electrodes 
The high selectivity of K+ electrodes encouraged us to simplify the calibration process 
for K+ electrodes by using solutions composed of KCl and NaCl, where the total cation 
concentration was kept constant at 150 mM.  Recorded voltages were corrected for 
calculated liquid junction potentials and corrected voltages were subjected to a two-
dimensional fit to a simplified Nicolski equation:  
           V   K150AKlogSV 10Ki  
where symbols have the same meaning as above.  Again, K+ electrodes were found to 
be highly sensitive with SK+ near the theoretical value of 60 (54.9 ± 0.4, n=137) and 
highly selective with A near the ideal value of zero (0.018 ± 0.001, n=137).  Accordingly, 
the relationship between voltage and K+ was found to be non-linear (Figure 2.2C).   
36 
 
Figure 2.2: Selectivity and sensitivity of Na+ and K+-selective electrodes.    
Electrodes were calibrated using mixtures of NaCl and KCl and the resulting two- or three-dimensional 
data (red dots) were fitted to the Nicolski equation (black lines).  A) Three-dimensional calibration of K+ 
selective electrodes.  Curve 1: The KCl concentration was varied between 10 and 150 mM in the 
presence of a constant NaCl concentration of 10 mM.  Curve 2: The NaCl concentration was varied 
between 10 to 150 mM in the presence of a constant KCl concentration of 3 mM.  Curve 3: The NaCl 
concentration was varied between 10 to 150 mM in the presence of a constant KCl concentration of 35 
mM.  Curve 4: The NaCl concentration was varied between 10 to 150 mM in the presence of a constant 
KCl concentration of 68 mM.  Note, that K+ selective electrodes were highly selective for K+ which is 
evident from the steep relationship between the Voltage and the KCl concentration (Curve 1) and the flat 
relationships between the voltage and the NaCl concentration (Curves 2-4).  B) Three-dimensional 
calibration of Na+ selective electrodes.  Curve 1: The NaCl concentration was varied between 10 and 150 
mM in the presence of a constant KCl concentration of 3 mM.  Curve 2: The NaCl concentration was 
varied between 10 to 150 mM in the presence of a constant KCl concentration of 13 mM.  Curve 3: The 
KCl concentration was varied between 10 to 150 mM in the presence of a constant NaCl concentration of 
10 mM.  Note, that Na+ selective electrodes were highly selective for Na+ but, although to a lesser degree, 
also detected K+, which is evident from the steep relationships between the Voltage and the NaCl 
concentration (Curve 1 and 2)  and the less steep relationship between the voltage and the KCl 
concentration (Curve 3).  C) Two-dimensional calibration of K+ selective electrodes.  Calibration 
procedures were simplified by using solutions in which the sum of NaCl and KCl was maintained constant 
at 150 mM.   
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prenatal phase of development.  Therefore, we established an in vitro method where 
measurements of the transepithelial voltage and of endolymphatic ion concentrations 
are conducted in isolated superfused temporal bones.  This method was evaluated by 
comparing data from adult Slc26a4Δ/+ mice (P62-P72) that were obtained with the in situ 
technique and with the in vitro method (Figure 2.3).  Measurements in situ yielded an 
endolymphatic K+ concentration of 157 ± 14 (n=4) mM and an endocochlear potential at 
normoxic conditions of 95 ± 2 (n=6) mV.  Upon induction of anoxia by injection of 
succinylcholine, the endocochlear potential declined within 2-3 min to -29 ± 2 (n=6) mV, 
while the endolymphatic K+ concentration remained stable (153 ± 9 mM, n=4).  
Measurements in vitro were obtained within 10-15 min after sacrifice and yielded an 
endolymphatic K+ concentration of 144 ± 12 (n=6) mM, which is similar to results 
obtained in situ, and an endocochlear potential of -16 ± 3 (n=6) mV, which is similar to 
the anoxia potential found in situ.  These data suggest that the in vitro method is 
suitable to evaluate the K+ concentration, and presumably the Na+ concentration, and 
that in vitro measurements of the transepithelial potential more closely approximate 
anoxic rather than normoxic conditions.  
K+ concentration & voltage measurements in the cochlea & endolymphatic sac  
The in vitro method was used to determine the endolymphatic K+ concentration and the 
transepithelial potential in the cochlea and the endolymphatic sac during development.  
Measurements were made with double-barreled K+ selective electrodes in prenatal and 
neonatal Slc26a4Δ/+ and Slc26a4Δ/Δ mice (Figure 2.4).   
In the cochlea, the endolymphatic K+ concentration between age E14.5 and E17.5 was 
10.7 ± 0.7 (n=20) mM with no differences between Slc26a4Δ/+ and Slc26a4Δ/Δ mice 
(Figure 2.4A).  At E19.5, the endolymphatic K+ concentration began to rise in both 
genotypes.  At P0 and P3, the endolymphatic K+ concentrations in the cochlea of 
Slc26a4Δ/Δ mice was significantly lower compared to in Slc26a4Δ/+ mice, however, this 
difference disappeared with further development.  The perilymphatic K+ concentration 
was 3.29 ± 0.07 (n=72) mM and did not change with age and displayed no differences 
between genotypes.  Slc26a4Δ/+ mice developed a positive transepithelial voltage of 4.4 
± 1.7 (n=6) mV at E19.5 (Figure 2.4B).  With further development, the transepithelial 
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voltage became negative.  Transepithelial voltages in Slc26a4Δ/Δ mice remained close 
to zero till age P5, but was found to be negative in adult mice (-3.9 ± 0.5 mV, n=5).   
In the endolymphatic sac, the endolymphatic K+ concentration between ages E14.5 and 
E17.5 was 15.4 ± 1.6 (n=21) mM with no differences between Slc26a4Δ/+ and 
Slc26a4Δ/Δ mice (Figure 2.4C) and the transepithelial potential was -5.1 ± 0.7 (n=21) 
mM, again with no differences between Slc26a4Δ/+ and Slc26a4Δ/Δ mice (Figure 2.4D).  
Between ages E14.5 and E17.5, no difference was found between the endolymphatic 
K+ concentration in the cochlea and the endolymphatic sac.   
 
 
 
Figure 2.4: K+ concentration and voltage in the cochlea & the endolymphatic sac  
Summary of measurements of the endolymphatic K+ concentration and transepithelial voltage in vitro in 
the cochlea and the endolymphatic sac of Slc26a4Δ/+ (black symbols) and Slc26a4Δ/Δ mice (red 
symbols)..  A-B) Measurements in the cochlea.  C-D) Measurements in the endolymphatic sac.  
Measurements in Slc26a4Δ/Δ mice that differed significantly from measurements in Slc26a4Δ/+ mice are 
marked (*).   
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Na+ and K+ concentration measurements in the cochlea 
The in vitro method was further used to determine the endolymphatic Na+ and K+ 
concentrations in the cochlea of Slc26a4Δ/+ and Slc26a4Δ/Δ mice at ages E16.5 and P0 
(Figure 2.5).  At both ages the endolymphatic K+ concentration had been found in both 
genotypes to be significantly higher than the perilymphatic K+ concentration and the 
transepithelial voltage had been found to be zero, see above.  Measurements were 
made with double-barreled Na+ and K+ selective electrodes.  Recordings with the K+ 
electrode were used as indicator of a successful penetration into scala media (Figure 
2.5A and B).   
At age E16.5, the endolymphatic Na+ and K+ concentrations in the cochlea were 141 ± 3 
(n=8) mM and 9.6 ± 0.3 (n=8) mM, respectively.  No differences were detected between 
Slc26a4Δ/+ and Slc26a4Δ/Δ mice.  At age P0, the endolymphatic Na+ dropped in 
Slc26a4Δ/+ mice to 80 ± 12 (n=3) mM and the endolymphatic K+ concentrations rose to 
80 ± 14 mM (n=3).  Smaller changes were observed in Slc26a4Δ/Δ mice where the 
endolymphatic Na+ concentration dropped to 131 ± 4 (n=3) mM and the K+ 
concentration rose to 31 ± 2 (n=3) mM.  No difference was found between the 
genotypes in the sum of the Na+ and the K+ concentration (Figure 2.5C and D).  At 
E16.5 the sum was 151 ± 3 (n=8) and at P0 the sum was 160 ± 5 (n=6).  The 
perilymphatic Na+ and K+ concentrations did not vary with genotypes or age and were 
147 ± 3 (n=14) mM and 4.2 ± 0.3 (n=14) mM, respectively.  The sum of the 
perilymphatic Na+ and K+ concentrations was 151 ± 3 mM (n=14).  
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Figure 2.5: Endolymphatic Na+ and K+ concentrations in vitro.   
Measurements of the endolymphatic Na+ and K+ concentrations in vitro.  A) Representative traces of the 
Na+ (red) and K+ (black) concentration in the cochlea of an Slc26a4Δ/+ mouse at age E16.5.  B) 
Representative traces of the Na+ (red) and K+ (black) concentration in the cochlea of an Slc26a4Δ/+ mouse 
at age P0.  C-D) Summary of Na+ and K+ concentration measurements in cochlear endolymph in 
Slc26a4Δ/+ and Slc26a4Δ/Δ mice at age E16.5 and P0.  Numbers next to bars represent the number of 
animals. 
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HCO3- and Cl- concentration estimations in the cochlea  
The HCO3- concentrations in cochlear endolymph were estimated under the 
assumptions that CO2, HCO3- and pH are in equilibrium such that the HCO3- 
concentration can be calculated based on measurements of the endolymphatic pH.  In 
the cochlea at age ~E16.5, the endolymphatic pH had been reported to be pH ~7.44 in 
Slc26a4Δ/+ mice and pH ~7.11 in Slc26a4Δ/Δ mice and the perilymphatic pH had been 
reported to be pH 7.30 in both genotypes [102].  According to the Henderson-
Hasselbalch equation, 
 






 
0.03
HCO  
log pK pK 310a CO2P  
where pKa is the logarithmic acid dissociation constant (pKa = 6.1), ‘0.03’ is the solubility 
of CO2 in water and PCO2 is the partial pressure of CO2 (PCO2 = 5%), the endolymphatic 
HCO3- concentration was calculated to be 25 mM in Slc26a4Δ/+ mice and 11.7 mM in 
Slc26a4Δ/Δ mice and 18 mM in perilymph of both genotypes.  With further development, 
based on endolymphatic pH measurements at P10, the endolymphatic HCO3- 
concentration was calculated to be 35 mM in Slc26a4Δ/+ mice and 10.5 mM in 
Slc26a4Δ/Δ mice [81].   
The Cl- concentration in cochlear endolymph was estimated under the assumptions that 
Na+, K+, Cl- and HCO3- are the major ions in cochlear endolymph, and that the sum of 
anions matches the sum of cations.  Accordingly, the endolymphatic Cl- concentration at 
age ~E16.5 was estimated to be 126 mM (=151-25) in Slc26a4Δ/+ and 139 mM (=151-
11.7) in Slc26a4Δ/Δ mice and the perilymphatic Cl- concentration was estimated to be 
133 mM (=151-18) in both genotypes.  
 
Cochlear expression of Atp1a1, Slc12a2, Kcnq1, Scnn1a, Scnn1b & Scnn1g  
The molecular mechanism for K+ secretion into endolymph has been established in the 
adult cochlea where K+ is taken up across the basolateral membrane of stria marginal 
cells via the Na+/K+ ATPase that contains the α-subunit ATP1A1 and the Na+/2Cl-/K+ 
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cotransporter SLC12A2.   K+ is then secreted into endolymph via the apical K+ channel 
KCNQ1 [21,23].  Whether this mechanism is responsible for the prenatal rise in the 
endolymphatic K+ concentration is not unknown.   
Cochlear mRNA expression of Atp1a1, Slc12a2 and Kcnq1 was quantified between 
ages E14.5 and P8 and the onset and localization of SLC12A2 and KCNQ1 protein 
expression was determined in the cochlea of Slc26a4Δ/+ and Slc26a4Δ/Δ mice.  
Expression levels of Atp1a1 mRNA rose nearly in parallel between age E14.5 and P8 in 
Slc26a4Δ/+ and Slc26a4Δ/Δ mice (Figure 2.6A) with the exception that between E17.5 
and P0 a steeper rise was observed in Slc26a4Δ/Δ mice compared to Slc26a4Δ/+ mice.  
In contrast, expression levels of Slc12a2 and Kcnq1 were stable between E14.5 and 
E17.5, increased between E17.5 and P0, where stable between P0 and P4 and then 
increased between P4 and P8 with no differences between genotypes (Figure 2.6B and 
C).   
Cryosections were prepared from the cochlea of Slc26a4Δ/+ and Slc26a4Δ/Δ mice and 
revealed in Slc26a4Δ/Δ mice the dramatic enlargement of scala media (Figure 2.7).  At 
E17.5, no protein expression of SLC12A2 or KCNQ1 was detected, however, 
expression of both proteins was found at E19.5 in Slc26a4Δ/+ and Slc26a4Δ/Δ mice.  
Expression of SLC12A2 was detected in the basolateral membrane of strial marginal 
cells and in the basolateral membranes of epithelial cells in Kölliker’s organ and 
expression of KCNQ1 was found in the apical membrane of strial marginal cells.  No 
difference in the location of expression was detected between Slc26a4Δ/+ and 
Slc26a4Δ/Δ mice.  These results are based on the evaluation of 2-3 pairs of Slc26a4Δ/+ 
and Slc26a4Δ/Δ littermates that were collected from two timed-pregnant dams per 
gestational age.  
The molecular mechanism for Na+ absorption has been established for the adult 
cochlea in Reissner’s membrane epithelial cells as well as in outer sulcus epithelial cells 
and Claudius’ cells [25,136,137].  Outer sulcus epithelial cells absorb cations from 
endolymph including Na+ and K+, however, Reissner’s membrane and Claudius’ 
epithelial cells selectively absorb Na+ across the apical membrane via the Na+ channel 
ENaC which consists of the subunits Scnn1a, Scnn1b and Scnn1g.  Cochlear mRNA 
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expression of the three ENaC subunits was quantified in Slc26a4Δ/+ and Slc26a4Δ/Δ 
mice between the ages E14.5 and P8.   
 
Figure 2.6: mRNAs encode selected Na+ and K+ channels and transporters  
Expression of mRNAs that code for selected Na+ and K+ channels and transporters in the cochlea of 
Slc26a4Δ/+  and Slc26a4Δ/Δ mice.  A) The α-subunit of the Na+/K+ ATPase Atp1a1.  B)  The Na+/2Cl-/K+ 
cotransporter Slc12a2.  C) The α-subunit of the K+ channel Kcnq1.  D-F) The α-, β- and γ-subunit of the 
Na+ channel ENaC.  Measurements in Slc26a4Δ/Δ mice that differed significantly from measurements in 
Slc26a4Δ/+ mice are marked (*).   
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Expression levels of Scnn1a were stable during the time of observation and did not 
differ between Slc26a4Δ/+ and Slc26a4Δ/Δ mice (Figure 2.6D).  In contrast, expression 
levels of Scnn1b rose in Slc26a4Δ/+ mice between P4 and P8 and in Slc26a4Δ/Δ mice 
between E14.5 and E17.5, which is 9-15 days earlier (Figure 2.6E).  Similarly, 
expression levels of Scnn1g rose between E17.5 and P0 in Slc26a4Δ/+ mice and 
between E14.5 and E17.5 in Slc26a4Δ/Δ mice, which is 1-5 days earlier (Figure 2.6F).  
With the exception of the measurement at E17.5, no difference in expression levels of 
Scnn1g were observed between Slc26a4Δ/+ and Slc26a4Δ/Δ mice.   
 
Discussion 
The most salient findings of the present study are that endolymph in the cochlea and 
the endolymphatic sac of Slc26a4Δ/+ and Slc26a4Δ/Δ mice is a NaCl rich fluid during the 
phase of cochlear growth and enlargement (Figure 2.4 and 2.5), that the onset of the 
rise in the K+ concentration in the cochlea occurs prenatally and coincides with a decline 
in the Na+ concentration (Figure 2.5), and that the rise in the K+ concentration in the 
cochlea coincides with the onset of expression of the Na+/2Cl-/K+ cotransporter 
SLC12A2 and the K+ channel KCNQ1 (Figure 2.7).  
The molecular mechanisms for K+ secretion into endolymph have been well established 
in the adult cochlea, where K+ secretion is mediated by marginal cells of stria vascularis 
[6,23].  Marginal cells take up K+ across the basolateral membrane via the Na+/K+-
ATPase and the Na+/2Cl-/K+-cotransporter SLC12A2 and secrete K+ into endolymph 
across the apical membrane via the K+ channel KCNQ1/KCNE1 (formerly called IsK 
and MinK).  The presented data suggest that this mechanism becomes operational with 
the onset of expression of SLC12A2 and KCNQ1 between E17.5 and E19.5 resulting in 
a rise of endolymphatic K+ concentration in Slc26a4Δ/+ and Slc26a4Δ/Δ mice (Figures 2.4 
and 2.7).  Notably, the onset of the rise in the endolymphatic K+ concentration was 
found to occur prenatally, at E19.5 (Figure 2.4A), which is ~5 days earlier than the 
previously reported onset at P3 that was based on serially-sectioned freeze-dried 
labyrinths and X-ray analysis of elemental composition [138,139].  The expression of 
SLC12A2 in the cochlea, however, was not limited to strial marginal cells but was also 
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found in the basolateral membrane of epithelial cells in Köllikers organ (Figure 2.7).  
These cells, which are lost during early postnatal development, have previously been 
shown to express Na+/K+-ATPase, which suggest they may be engaged in ion secretion 
[3].  Whether and what ions are transported across the apical membrane is not known.   
 
 
Figure 2.7: Protein of KCNQ1 and SLC12A2 in the cochlea.   
Expression of protein of the K+ channel KCNQ1 and the Na+/2Cl-/K+ cotransporter SLC12A2 in the 
cochlea.  A-D) Expression of KCNQ1 (red) in the cochlea of Slc26a4Δ/+ and Slc26a4Δ/Δ mice at ages 
E17.5 and E19.5.  E-H) Expression of SLC12A2 (red) in the cochlea of Slc26a4Δ/+ and Slc26a4Δ/Δ mice at 
ages E17.5 and E19.5.  Note that the onset of expression of KCNQ1 and SLC12A2 occurred in 
Slc26a4Δ/+ and Slc26a4Δ/Δ mice between E17.5 and E19.5.   Further, note that images of Slc26a4Δ/+ and 
Slc26a4Δ/Δ mice are reproduced at the same magnification to illustrate the dramatic enlargement in 
Slc26a4Δ/Δ mice.  Stains included DAPI for nuclei (blue) and phalloidin for F-actin (green).  Abbreviations: 
SV, Stria vascularis; K, Köllikers organ.   
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The molecular mechanism for Na+ absorption is well established in Reissner’s 
membrane and Claudius’ epithelial cells of the adult cochlea, where Na+ absorption 
from endolymph in mediated via the Na+ selective channel ENaC and Na+ is extruded 
across the basolateral membrane via the Na+/K+-ATPase [136,137] .  Other epithelial 
cells, such as outer sulcus cells and sensory hair cells, also absorb Na+ but do not 
distinguish between Na+ and K+ absorption since their major apical cation channel is a 
cation non-selective channel [26,140].  The presented quantification of mRNA 
expression suggest that regulation of Na+ absorption, if present, does not occur at the 
transcriptional level of the channel-forming α-subunit Scnn1a or the accessory γ-subunit 
Scnn1g, but occurs possibly at the transcriptional level of the β-subunit Scnn1b and at 
translational or regulatory levels.  Interestingly, our observation of upregulation of the β-
subunit between P4 and P8 coincides with the onset of amiloride-sensitive Na+ transport 
in Reissner’s membrane [141].   
The onset of the rise in the K+ concentration coincided with the observation of a positive 
transepithelial potential at E19.5 in Slc26a4Δ/+ mice (Figure 2.4B).  This transepithelial 
potential may be generated by marginal cells of stria vascularis, which have been 
shown to generate a positive transepithelial potential when bathed at the apical 
membrane with a Na+-rich solution [23].  This positive potential, however, is different 
from the endocochlear potential that is generated across the basal cell barrier of stria 
vascularis, begins to rise at P5, develops within ~10 days to levels of 90 -100 mV 
(Figure 2.3), and is exquisitely sensitive to anoxia [135].  The positive endocochlear 
potential is essentially a K+ diffusion potential that is generated by the K+ channel  
KCNJ10 that is located in intermediate cells of stria vascularis, which are part of the 
basal cell barrier [6].   
From P3 onward, a negative transepithelial potential was found in the cochlea (Figure 
2.4B).  Negative potentials of similar magnitude have been recorded in situ under 
anoxic conditions [135].  The negative potentials recorded in vitro are most likely anoxia 
potentials that were recorded since our experimental conditions did not maintain 
normoxic conditions, which are necessary for the positive endocochlear potential.  This 
shortcoming, however, has been shown to not affect the outcome of the ion 
measurements (Figure 2.3C).  The negative endocochlear potential found under anoxic 
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conditions (Figure 2.3D) is a K+ diffusion potential that is thought to be generated by K+ 
channels in the basolateral membrane of the sensory hair cells and that depends on the 
openness of the non-selective transduction channel in the apical membrane of the 
sensory cells.  Since the present measurements of the transepithelial potential were 
conducted in vitro, which mimics anoxic conditions, the presence of the negative 
transepithelial potential observed from P3 onward indicates the presence of mature 
sensory hair cells.  This observation is consistent with previous findings on the opening 
of the transduction channels in murine cochlear hair cells at neonatal stage [142].  The 
observation that up to P5 neither a positive nor a negative potential was observed in the 
cochlea of Slc26a4Δ/Δ mice may be related to a retardation of development [116].  
The rise in the K+ concentration during the neonatal phase of development was found to 
be delayed by ~3 days in Slc26a4Δ/Δ mice since K+ concentrations reached similar 
levels at P0 in Slc26a4Δ/+ mice and P3 in Slc26a4Δ/Δ mice.  This delay in the 
concentration change may in part be due to the ~10 fold larger volume of scala media in 
Slc26a4Δ/Δ mice compared to Slc26a4Δ/+ mice that would require a ~10 fold higher rate 
of K+ secretion and Na+ absorption [3].  This delay, however, may also, at least in part, 
be due to a delayed vascularization of stria vascularis in Slc26a4Δ/Δ mice that had been 
observed at P3 [102].  
The endolymphatic sac has been shown to reabsorb fluid and thereby drain the cochlea 
during the phase of cochlear lumen formation in Slc26a4Δ/+ mice.  Failure to drain the 
cochlea leads to enlargement of the cochlea in Slc26a4Δ/Δ mice [3].  It is conceivable 
that loss of Slc26a4 disrupts NaCl absorption and thereby leads to the enlargement.  
The negative transepithelial potential found in the prenatal endolymphatic sac (Figure 
2.4D) is consistent with electrogenic Na+ absorption mediated by a channel such as 
ENaC, which has been found to be expressed in the endolymphatic sac [143].  Whether 
ENaC or other ion transporters mediate fluid absorption in the endolymphatic sac is 
beyond the scope of the present study.   
In summary, we have determined 1) that endolymph in the cochlea and the 
endolymphatic sac of Slc26a4Δ/+ and Slc26a4Δ/Δ mice is a NaCl rich fluid during the 
phase of cochlear growth and enlargement, 2) that the onset of K+ secretion occurs in 
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the cochlea prenatally, and 3) that the rise in the K+ concentration coincides with the 
onset of expression of the K+ channel KCNQ1 and the Na+/2Cl-/K+ cotransporter 
SLC12A2.  The determination of the ionic composition of endolymph during the phase 
of cochlear growth in Slc26a4Δ/+ mice and enlargement in Slc26a4Δ/Δ mice presents an 
important first step toward elucidating mechanisms that cause the enlargement.  The 
elucidation of these mechanisms is important for the identification of drug targets that 
can be exploited to prevent enlargement and restore normal cochlear development in 
patients carrying mutations of SLC26A4.   
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Chapter 3  Rescue of hearing and balance in Slc26a4 
mutant mice 
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Abstract 
Mutations of SLC26A4 are a common cause of human hearing loss associated with 
enlargement of the vestibular aqueduct.  SLC26A4 encodes pendrin, an anion 
exchanger expressed in a variety of epithelial cells in the cochlea, the vestibular 
labyrinth and the endolymphatic sac.  Slc26a4∆/∆ mice are devoid of pendrin and 
develop a severe enlargement of the membranous labyrinth, fail to acquire hearing and 
balance, and thereby provide a model for the human phenotype.  Here, we generated a 
transgenic mouse line that expresses human SLC26A4 controlled by the promoter of 
ATP6V1B1.  Crossing this transgene into the Slc26a4∆/∆ line restored protein expression 
of pendrin in the endolymphatic sac without inducing detectable expression in the 
cochlea or the vestibular sensory organs.  The transgene prevented abnormal 
enlargement of the membranous labyrinth, restored a normal endocochlear potential, 
normal pH gradients between endolymph and perilymph in the cochlea, normal otoconia 
formation in the vestibular labyrinth and normal sensory functions of hearing and 
balance.  Our study demonstrates that restoration of pendrin to the endolymphatic sac 
is sufficient to restore normal inner ear function.  This finding in conjunction with our 
previous report that pendrin expression is required for embryonic development but not 
for the maintenance of hearing opens the prospect that a spatially and temporally 
limited therapy will restore normal hearing in human patients carrying a variety of 
mutations of SLC26A4.  
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Author Summary 
Mutations of SLC26A4 are the most common cause for hearing loss associated with a 
swelling of the inner ear.  This human disease is largely recapitulated in a mutant 
mouse model.  Mutant mice lack Slc26a4 expression and their inner ears swell during 
embryonic development, which leads to failure of the cochlea and the vestibular organs 
resulting in deafness and loss of balance.   
SLC26A4 is normally found in the cochlea and vestibular organs of the inner ear as well 
as in the endolymphatic sac, which is a non-sensory part of the inner ear.  The multitude 
of sites where SLC26A4 is located made the goal to restore function through restoration 
look futile, unless some sites were more important than others.   
Here, we generated a new mutant mouse that expresses SLC26A4 in the 
endolymphatic sac but not in the cochlea or the vestibular organs of the inner ear.  
Fantastically, this mouse did not develop the detrimental swelling of the inner ear and 
even more exciting, the mouse developed normal hearing and balance.   
Our study provides the proof-of-concept that a therapy aimed at repairing the 
endolymphatic sac during embryonic development is sufficient to restore a life-time of 
normal hearing and balance.   
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Introduction 
Enlargement of the vestibular aqueduct (EVA; OMIM #600791) is a malformation of the 
temporal bone that is commonly observed in children with sensorineural hearing loss 
[30,31,144–146].  Mutations of SLC26A4 are the most common cause for EVA-
associated hearing loss that can either be non-syndromic (DFNB4; OMIM # 600791) or 
syndromic with enlargement of the thyroid gland (Pendred syndrome; OMIM #274600).  
SLC26A4 codes for the anion exchanger pendrin that transports anions such as Cl-, I- 
and HCO3- [63,65].   
 
Figure 3.1: Schematic diagram of the inner ear.  
A) Diagram of the membranous labyrinth.  The two continuous luminal fluid spaces of the mature inner 
ear are filled with endolymph (pink and purple).  B-E) Diagrams of a cross section of one cochlear turn (B), 
of the utricle or saccule (C), of one ampulla (D) and the endolymphatic sac (E).  Cells that express 
pendrin (yellow cells pointed to by arrows) are diagrammed in mature tissues.   
 
Although EVA is a malformation of the temporal bone, it is not the cause for hearing 
loss since no correlation was found between the degree of EVA and the severity of 
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hearing impairment [36].  EVA, however, is an indication of an enlargement of the 
endolymphatic duct epithelium that was present during embryonic development.  
Cartilage cells that form in the periphery of the endolymphatic duct epithelium preserve 
the diameter of the duct in a ‘fossil-like’ record when they give rise to the bone of the 
vestibular aqueduct.    
 
The mature inner ear consists of seven interconnected fluid spaces that house six 
sensory organs (Figure 3.1):  The cochlea for hearing, the utricle and saccule for 
sensing linear acceleration including gravity, and three ampullae with semicircular 
canals for sensing angular acceleration in three spatial axes.  The seventh fluid 
compartment is the endolymphatic duct and sac, which is devoid of sensory cells and 
which is suspected to play a role in fluid homeostasis [3,147].  Pendrin is expressed in a 
variety of epithelial cells that enclose endolymph, which is the luminal fluid of the inner 
ear (Figure 3.1).  Pendrin is expressed in outer sulcus, spiral prominence and spindle-
shaped cells in the cochlea, transitional cells in the utricle, saccule and ampullae and 
mitochondria-rich cells (synonym: Forkhead-related or FORE cells) of the 
endolymphatic sac [66,101].  Each cell type represents a small domain in the 
heterogeneous epithelium that encloses endolymph.  The many locations and cell types 
that express pendrin in a normal inner ear made the goal to restore function through 
restoration of expression look futile unless some sites of expression were more 
important than others.   
 
The earliest onset of pendrin expression in the murine inner ear occurs in the 
endolymphatic sac at embryonic day E11.5, which precedes the onset of expression in 
the cochlea by 3 days, in the saccule and utricle by 4 days, and in the ampullae by 5 
days [102].  The expression in the endolymphatic sac surges dramatically at E14.5, a 
time in development when there is very little pendrin expressed elsewhere in the inner 
ear [102].   
 
Studies in a mouse model, Slc26a4∆/∆, have revealed that loss of pendrin leads to an 
enlargement of endolymph volume followed by an acidification and a failure to develop 
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normal hearing and balance [102,103].  The onset of the enlargement in the cochlea 
and the endolymphatic sac occurs at E14.5 which precedes the onset of the luminal 
acidification by 1 day in the cochlea and by 3 days in the endolymphatic sac [102].  The 
enlargement develops in Slc26a4∆/∆ mice between E14.5 and E18.5, which is the phase 
of rapid growth of the cochlea [31].  The coincidence of the surge in pendrin expression 
in the endolymphatic sac at E14.5 and the onset of the enlargement in Slc26a4∆/∆ mice 
points to the importance of pendrin expression in the endolymphatic sac for inner ear 
fluid homeostasis.     
 
We hypothesized that restoration of pendrin expression in the endolymphatic sac would 
prevent enlargement and permit normal development of the cochlea and the vestibular 
labyrinth including the acquisition of sensory function.  To test this hypothesis, we 
generated a mouse line that expresses human pendrin SLC26A4 controlled by the 
promoter of the B1-subunit of the human vacuolar H+ ATPase (ATP6V1B1) and crossed 
this transgene into the Slc26a4∆/∆ line to generate mice that lack expression of mouse 
pendrin but express human pendrin in the endolymphatic sac.  No expression of pendrin 
protein was detected in these mice in the cochlea or the vestibular labyrinth but in 
mitochondria-rich cells of the endolymphatic sac.  Analysis of this mouse model 
revealed normal hearing and balance function.  Our data indicate that the expression of 
pendrin solely in the endolymphatic sac of the inner ear is sufficient to permit the 
development of normal hearing and balance.   
 
Results 
Generation of Tg(+);Slc26a4∆/∆ transgenic mice  
A transgenic mouse line, referred to as Tg(B1-hPDS)Tg/+;Slc26a4+/+ and abbreviated 
here to Tg(+);Slc26a4+/+, was created by the laboratory of Dr. Dominique Eladari (Paris, 
France) [148].  This mouse expresses human SLC26A4 (formerly named hPDS) 
controlled by the promoter of ATP6V1B1, which codes for the B1-subunit of the 
vH+ATPase.  Transgenic founders were crossed with wild-type C57BL/6 x CBA F1 mice 
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and three Tg(+);Slc26a4+/+ mice were shipped to Kansas State University (Manhattan, 
Kansas, USA).   
 
 
Figure 3.2: Atp1a1, Atp6v1b1, Slc26a4 & SLC26A4 mRNA levels in inner ear  
Expression was determined by quantitative RT-PCR performed on total RNA.  Total RNA was isolated 
from microdissected tissues obtained from Tg(-);Slc26a4∆/+ (A-D) and Tg(+);Slc26a4∆/∆ mice (E-H).  
Endolymphatic sacs (ES) were isolated from mice at age E17.5.  Cochleae were isolated at ages E17.5 
(C1) and P2 (C2).  Vestibular labyrinths (VL), consisted of saccule, utricle, ampullae and semicircular 
canals without endolymphatic sacs, were isolated at age P8.  The expression of endogenous mouse 
Atp1a1, Atp6v1b1, and Slc26a4, and of transgenic human SLC26A4 mRNA was normalized to the 
expression of 18S rRNA.  Note that the expression pattern of human SLC26A4 in Tg(+);Slc26a4∆/∆ mice 
resembles the pattern of mouse Slc26a4 in Tg(-);Slc26a4∆/+ mice (both patterns highlighted in red).  
Numbers inside graphs represent the number of experiments. (Experiments conducted by XL and FZ)  
 
At Kansas State University, Tg(+);Slc26a4+/+ mice were crossed with Slc26a4∆/∆ mice, 
which are maintained in an isogenic 129S6SvEv background, to generate the desired 
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Tg(+);Slc26a4∆/∆ mice in an F2 generation.  Expression of SLC26A4 (human pendrin) in 
this mouse was expected to originate solely from the transgene since Exon 8 in the 
Slc26a4∆ allele was replaced with a neomycin-cassette that introduced a frame-shift 
[103].  Littermates with the genotype Tg(-);Slc26a4∆/∆ served as negative controls.  
These mice were expected to lack functional pendrin protein expression. Further, 
littermates with genotypes Tg(-);Slc26a4∆/+, Tg(+);Slc26a4∆/+, and Tg(+);Slc26a4+/+ 
served as positive controls.  These mice were expected to express murine pendrin with 
or without augmentation of human pendrin and have normal hearing and balance.    
 
mRNA expression 
Expression of Atp1a1, Atp6v1b1, Slc26a4 and SLC26A4 was determined by 
quantitative RT-PCR and normalized to the expression of 18S rRNA (Figure 3.2).  The 
highest levels of Atp6v1b1 and Slc26a4 mRNA among the different inner ear tissues 
were found in the endolymphatic sac (Figure 3.2B and C).  Expression of Slc26a4 was 
reduced by factors between 6 and 16 in Tg(+);Slc26a4∆/∆ mice compared to Tg(-
);Slc26a4∆/+ mice (Figure 3.2C vs G).  Expression levels of Atp1a1 and Atp6v1b1 
exhibited a similar pattern among inner ear tissues of Tg(-);Slc26a4∆/+ and 
Tg(+);Slc26a4∆/∆ mice (Figure 3.2A vs E and Figure 3.2B vs F).  Most interesting, 
expression levels of human SLC26A4 in Tg(+);Slc26a4∆/∆ resembled the pattern of 
mouse Slc26a4 in Tg(-);Slc26a4∆/+ mice with the highest levels being expressed in the 
endolymphatic sac (Figure 3.2C vs H).  Whether or not expression levels of human 
SLC26A4 in Tg(+);Slc26a4∆/∆ exceeded expression levels of mouse Slc26a4 in Tg(-
);Slc26a4∆/+ mice remained undetermined, since the efficiency of the reverse 
transcription of mRNA into cDNA remains generally unknown in quantitative RT-PCR 
experiments.  Taken together, the data demonstrate that the transgene restored pendrin 
mRNA expression to the endolymphatic sac, the cochlea and the vestibular labyrinth of 
the inner ear.   
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Figure 3.3: Transgene-encoded eGFP expression.  
A-C) Expression of eGFP was monitored as direct fluorescence in cochlear ducts (A), endolymphatic 
sacs (B), and kidney slices (C) freshly isolated from E15.5 Tg(B1-eGFP) mice.  The outline of the imaged 
tissues is marked (dashed-line).  D-I) Expression of eGFP was evaluated by immunocytochemistry in the 
cochlea (D), utricle (E), ampulla (F), endolymphatic sac (G), kidney cortex (H), and kidney medulla (I) 
from E15.5 Tg(B1-eGFP) mice.  Staining consisted of immunocytochemistry of eGFP (green), F-actin 
(red) and nucleic acids (blue).  The number of mice represented by these images are 2 for images A-C 
and 2 for images D-I.  MR, mitochondria-rich cells; IC, intercalated cells; Lim, spiral limbus; K, Kölliker’s 
organ; OS, outer sulcus; SV, stria vascularis;  HC, vestibular hair cells; TC, transitional cells; M, 
melanocytes.  (Experiments conducted by PW, NP and XL) 
 
Protein expression - eGFP expression 
The ability of the ATP6V1B1 promoter to drive protein expression in different tissues 
including the cochlea, the vestibular labyrinth and the endolymphatic sac was evaluated 
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in a transgenic mouse line, Tg(B1-eGFP) in which the expression of eGFP is controlled 
by the same 6.9 kb promoter of the human ATP6V1B1 gene that drives the expression 
of human pendrin in Tg(+);Slc26a4∆/∆ mice [149].  No expression of eGFP was detected 
in the cochlea or the vestibular labyrinth of E15.5 Tg(B1-eGFP) mice, although 
expression was present in the endolymphatic sac and the kidney (Figure 3.3).  These 
data suggest that the ATP6V1B1 promoter does not drive protein expression in the 
cochlea or the vestibular labyrinth.   
 
Protein expression - Western blotting 
Soft tissues of the cochlea and the vestibular labyrinth, exclusive of the endolymph sac, 
were collected from adult mice by microdissection and pooled into an ‘inner ear’ sample.  
Crude membrane protein preparations were obtained from these inner ear samples and 
from kidneys and subjected to gel-electrophoresis and Western blotting.  Membrane 
proteins were obtained from Tg(+);Slc26a4∆/∆ mice as well as from Tg(-);Slc26a4∆/+ 
mice, which served as positive controls, and from Tg(-);Slc26a4∆/∆ mice, which served 
as negative controls.  Pendrin was detected in the inner ear and kidney of Tg(-
);Slc26a4∆/+ mice as a ~110 kDa band (Figure 3.4A).  Inner ear from Tg(+);Slc26a4∆/∆ 
mice lacked this band.  The observation that there was no difference in the pattern of 
faint bands between inner ears from Tg(+);Slc26a4∆/∆ mice and Tg(-);Slc26a4∆/∆ mice, 
which is the negative control, suggests that pendrin was either not detectable or not 
present.  The pendrin band, however, was found in kidney from Tg(+);Slc26a4∆/∆ mice 
(Figure 3.4B), which suggests that the antibody recognizes both mouse and human 
pendrin.   The observation that pendrin was detected at similar levels in descending 
amounts of kidney proteins isolated from Tg(-);Slc26a4∆/+ mice (Figure 3.4A) and 
Tg(+);Slc26a4∆/∆ mice (Figure 3.4C) suggests that the detection threshold for mouse 
and human pendrin was similar.  Whether the antibody differed in the sensitivity 
between mouse and human pendrin remains unknown, since the relative abundance of 
mouse pendrin in kidneys of Tg(-);Slc26a4∆/+ mice and human pendrin in kidneys of 
Tg(+);Slc26a4∆/∆ mice is not known.   
Figure 3
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The meaning of pendrin being not detectable in the inner ear was evaluated by 
comparison of the intensity of the pendrin band in inner ear to the intensities in 
descending amounts of kidney protein (Figure 3.4A).  This comparison suggests that a 
~5-fold lower amount pendrin should have been detectable in the inner ear.  This means 
that pendrin expression in the inner ear of Tg(+);Slc26a4∆/∆ mice is either absent or 
expressed at a level that does not exceed 20% of the expression level in Tg(-
);Slc26a4∆/+ mice.   
 
Paint-fill of the cochlea and the endolymphatic sac 
Temporal bones from Tg(+);Slc26a4∆/+ and Tg(+);Slc26a4∆/∆ mice were isolated at 
E15.5, fixed and injected with white paint (Figure 3.5A and B).  Most striking is that 
there was no enlargement of the endolymphatic sac, duct or cochlea in Tg(+);Slc26a4∆/∆ 
mice and that the morphology of Tg(+);Slc26a4∆/+ and Tg(+);Slc26a4∆/∆ mice was 
grossly similar.   These data demonstrate that the introduction of the transgene rescued 
the malformation previously described in Slc26a4∆/∆ mice [3,103].   
 
Histology and pendrin expression in the endolymphatic sac  
Whole-mounted specimens of the endolymphatic sac were prepared for 
immunocytochemistry from Tg(+);Slc26a4∆/∆, Tg(-);Slc26a4∆/∆, and Tg(+);Slc26a4∆/+ 
mice (Figure 3.5C-E).  Most striking is the enlargement and lack of pendrin expression 
in the endolymphatic sac of Tg(-);Slc26a4∆/∆ mice (Figure 3.5E) and the similarity in size 
and similarity in pendrin expression between the endolymphatic sac of Tg(+);Slc26a4∆/∆ 
mice (Figure 3.5C) and Tg(+);Slc26a4∆/+ mice (Figure 3.5D).  These data demonstrate 
that the transgene drives pendrin expression in the endolymphatic sac and that the 
introduction of the transgene rescued the malformation[3,103].   
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Figure 3.5: Histology and pendrin expression in the endolymphatic sac.   
A-B) Paint filled inner ears from Tg(+);Slc26a4∆/∆ and Tg(+);Slc26a4∆/+ mice at age E15.5.  Note that 
neither the endolymphatic duct (E. duct) nor the endolymphatic sac (E. sac) were enlarged.  C-E) Pendrin 
protein expression in the endolymphatic sac at age E16.5.  Staining consisted of immunocytochemistry of 
pendrin (red) and F-actin (green).  Images provide comparison of whole mounts from Tg(+);Slc26a4∆/∆ 
mice (C), Tg(+);Slc26a4∆/+ mice (D), and Tg(-);Slc26a4∆/∆ mice (E).  Note that images C-E are presented 
at the same scale.  The number of mice represented by these images is 2 for A, 2 for B, 3 for C, 4 for D, 
and 1 for E. MR, mitochondria-rich cells.  (Experiments conducted by XL) 
 
Gross morphology of the cochlea 
Gross morphological examination of inner ears revealed greater similarity between 
Tg(+);Slc26a4∆/∆ mice and Tg(+);Slc26a4∆/+ than between Tg(+);Slc26a4∆/∆ mice and 
Tg(-);Slc26a4∆/∆ mice (Figure 3.6A-C).  Cochlear turns in Tg(+);Slc26a4∆/∆ mice 
appeared normal in width and did not show widening of turns or thinning of the otic 
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capsule that was seen in Tg(-);Slc26a4∆/∆ and that was previously described in 
Slc26a4∆/∆ mice [101,116].  Inspection of the oval window revealed ‘glittering’ otoconia 
in the saccule in Tg(+);Slc26a4∆/∆ and Tg(+);Slc26a4∆/+ mice in contrast to Tg(-
);Slc26a4∆/∆ mice where no ‘glittering’ was visible (Figure 3.6D-F).    
 
 
Figure 3.6: Gross morphology of the cochlea isolated by microdissection.   
A-C) Overview images of cochleae from a Tg(-);Slc26a4∆/∆, Tg(+);Slc26a4∆/∆ and Tg(+);Slc26a4∆/+ mice.  
The width of the lower cochlear turn is marked with arrows and the round (RW) and oval window (OW) 
are labeled.  A region with apparently thinner bone is marked (*).  D-F) Enlarged view of the oval window.  
Normal otoconia in the saccule that reflect the light and appear bright white were seen in Tg(+);Slc26a4∆/∆ 
and Tg(+);Slc26a4∆/+ mice but not in Tg(-);Slc26a4∆/∆ (arrow).  The number of mice represented by these 
images is 1 for A and D, and 3 pairs for images B & C and E & F.  (Experiments conducted by XL) 
 
64 
Histology and pendrin expression in the cochlea 
Midmodiolar sections of cochlear tissues were prepared for immunocytochemistry from 
Tg(+);Slc26a4∆/∆ mice and positive controls consisting of Tg(-);Slc26a4∆/+ or 
Tg(+);Slc26a4∆/+ mice. No evidence for cochlear enlargement was found in 
Tg(+);Slc26a4∆/∆ mice at E16.5 (Figure 3.7B), P1 (Figure 3.13A), P16 (Figure 3.7A; 
Figure 3.13E) or P18 (Figure 3.13C) suggesting that the introduction of the transgene 
rescued the cochlear malformation previously described in Slc26a4∆/∆ mice, which 
includes a ~10-fold enlargement of the cochlea [101,103].  No detectable pendrin 
expression was found in the spiral prominence or outer sulcus epithelium of the cochlea 
in Tg(+);Slc26a4∆/∆ mice although prominent expression was observed in these cells in 
positive controls (Figure 3.7 and Figure 3.13).  The absence of pendrin in 
Tg(+);Slc26a4∆/∆ mice was observed with two different anti-pendrin antibodies (Pds #1 
and Pds #2).  The patterns of pendrin expression in the positive controls, Tg(-
);Slc26a4∆/+ and Tg(+);Slc26a4∆/+ mice, were similar for both antibodies to the pattern 
previously observed in Slc26a4∆/+ mice [101,102,150].  Expression of pendrin was 
further examined in whole-mounted specimens that encompassed the spiral limbus, 
organ of Corti and outer sulcus.  No detectable pendrin expression was found at age 
P35 in the spiral limbus of Tg(+);Slc26a4∆/∆ mice (Figure 3.7C) or Tg(-);Slc26a4∆/+ mice 
(Figure 3.7H) in contrast to the prominent expression of pendrin in the outer sulcus 
epithelia of Tg(-);Slc26a4∆/+ mice (Figure 3.7J).  For completeness, it needs to be 
reported that some punctate staining was found in nerve terminals near inner hair cells 
of Tg(+);Slc26a4∆/∆ (Figure 3.7D) and Tg(-);Slc26a4∆/+ mice (Figure 3.7I).   
 
Endocochlear potential and pH  
The endocochlear potential and the difference in pH between endolymph and perilymph 
was measured with double-barreled ion selective electrodes in Tg(-);Slc26a4∆/∆ mice, 
Tg(+);Slc26a4∆/+ mice, and Tg(+);Slc26a4∆/∆ mice (Figure 3.8).  Tg(-);Slc26a4∆/∆ mice 
failed to develop a normal endocochlear potential and the pH of endolymph was lower 
(= more acidic) than in perilymph, as previously reported [81].  In contrast, 
Tg(+);Slc26a4∆/+ mice, as reported for Slc26a4∆/+ mice [81], developed a normal 
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endocochlear potential and a normal endolymphatic pH that was higher (=more alkaline) 
than in perilymph.   Similar to Tg(+);Slc26a4∆/+ mice, Tg(+);Slc26a4∆/∆ mice developed a 
normal endocochlear potential and a normal endolymphatic pH even though no 
detectable pendrin expression was observed in the cochlear epithelium.  These data 
demonstrate that the introduction of the transgene, which rescued the malformation, 
also rescued the loss of the endocochlear potential and the loss of normal 
endolymphatic pH homeostasis.  
 
Hearing   
Hearing tests were based on auditory brain stem recordings and thresholds in response 
to tone bursts of 8 kHz, 16 kHz and 32 kHz.  Tests performed in Tg(+);Slc26a4+/+, Tg(-
);Slc26a4∆/∆ and Tg(+);Slc26a4∆/∆ mice confirmed profound deafness in Tg(-);Slc26a4∆/∆ 
mice (Figure 3.9B) consistent with previous findings in Slc26a4∆/∆ mice [81,81,103].  
Waveforms of auditory brain stem recordings as well as thresholds were similar 
between Tg(+);Slc26a4∆/∆ mice (Figure 3.9A) and Tg(+);Slc26a4∆/+ (Figure 3.9C).  
These findings demonstrate that the introduction of the transgene rescued normal 
hearing although the cochlea did not express detectable levels of pendrin.  We next 
evaluated whether the rescued hearing phenotype in Tg(+);Slc26a4∆/∆ would be stable 
through at least 3 months of age.  Auditory brain stem recordings were performed in 
Tg(+);Slc26a4∆/+ mice (Figure 3.9D-F),  in Tg(+);Slc26a4∆/∆ mice (Figure 3.9J-L), and in 
Tg(+);Slc26a4+/+ mice (Figure 3.9G-I) at 1, 2 and 3 month of age.  Hearing in 
Tg(+);Slc26a4∆/∆ mice at 8 kHz and 16 kHz was stable through 3 months.   Thresholds 
were very similar among individuals and did not differ from Tg(+);Slc26a4∆/+ and 
Tg(+);Slc26a4+/+ mice.  A greater variability in hearing thresholds was observed at 32 
kHz (Figure 3.9L), with 10 of the 19 Tg(+);Slc26a4∆/∆ mice maintaining excellent hearing 
(thresholds ≤30 dB at 32 kHz) and 5 developing a high-frequency hearing loss 
(thresholds ≥60 dB at 32 kHz).  About one half of the Tg(+);Slc26a4∆/∆ mice (9 of 19) 
developed progressive threshold elevations at 32 kHz with thresholds increasing by ≥10 
dB between the monthly measurements.  This variability is reflected in the greater error 
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bars at 32 kHz but did not lead to a statistically significant difference between 
Tg(+);Slc26a4∆/∆ and Tg(+);Slc26a4+/+ mice.   
 
Figure 3.7: Histology and pendrin expression in the cochlea.  
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Staining in all images consisted of immunocytochemistry of pendrin (Pds #1 antibody; red), F-actin 
(green) and nucleic acids (blue).  Images provide comparison of cryosections (A-B) and whole-mounted 
specimens (C-E) from Tg(+);Slc26a4∆/∆ mice to cryosections (F-G) and whole-mounted specimens (H-J) 
from Tg(-);Slc26a4∆/+ mice.  Whole-mounted specimens in C, E, H and J were imaged by detecting 
fluorescence in 25 optical sections that were recorded in 1 µm intervals and projected into a single plane.  
Whole-mounted specimens in D and I were imaged by detecting fluorescence in 8 optical sections that 
were recorded in 1 µm intervals, projected into a single plane and overlaid onto a single brightfield image.  
The number of pairs of mice represented by these images are 2 for image A & F, 3 for B & G, and 1 for 
C-E & H-J with 3 sections being evaluated per animal.  K, Kölliker’s organ; OS, outer sulcus; Lim, spiral 
limbus; IS, inner sulcus; OC, organ of Corti; SP, spiral prominence; SV, stria vascularis; RM, Reissner’s 
membrane.  Additional images using an alternative anti-pendrin antibody (Pds #2) and alternative positive 
controls (Tg(+);Slc26a4∆/+ mice) are provided in the Supplement (Fig. 3.13).  (Experiments conducted by 
XL) 
 
Histology and pendrin expression in the vestibular labyrinth 
Sections and whole-mounted specimens of vestibular tissues were prepared for 
immunocytochemistry from Tg(+);Slc26a4∆/∆ mice and positive controls consisting of 
Tg(-);Slc26a4∆/+ or Tg(+);Slc26a4∆/+ mice.  No evidence of pendrin expression was 
found in the three sensory organs in Tg(+);Slc26a4∆/∆ mice at P14 (Figure 3.14A), P16 
(Figure 3.10A,C,D and Figure 3.14C,G,K), P18 (Figure 3.14E), and P35 (Figure 3.10B).  
The absence of pendrin in Tg(+);Slc26a4∆/∆ mice was observed with two different anti-
pendrin antibodies (Pds #1 and Pds #2).  In contrast, pendrin expression was found in 
transitional cells of the utricle, saccule and ampullae of controls that consisted of Tg(-
);Slc26a4∆/+ or Tg(+);Slc26a4∆/+ mice.  The expression patterns in Tg(-);Slc26a4∆/+ and 
Tg(+);Slc26a4∆/+ mice with both antibodies were similar to the pattern previously 
described in Slc26a4∆/+ mice [101,150].   
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Figure 3.8: Endocochlear potential and pH.    
Endocochlear potential (A) and the difference between endolymphatic and perilymphatic pH (B) were 
measured in Tg(-);Slc26a4∆/∆, Tg(+);Slc26a4∆/+, and Tg(+);Slc26a4∆/∆ mice.  Numbers near the error bars 
represent the number of experiments.  (Experiments conducted by DH) 
 
Otoconia 
Vestibular labyrinths were isolated by microdissection from Tg(-);Slc26a4∆/∆, 
Tg(+);Slc26a4∆/∆ and Tg(+);Slc26a4∆/+ mice and the roof of the utricle was removed to 
permit an unobstructed view onto the utricular macula (Figure 3.11A-C).  Glittering 
otoconia were observed in Tg(+);Slc26a4∆/∆ and Tg(+);Slc26a4∆/+ mice and giant 
otoconia in Tg(-);Slc26a4∆/∆.  Otoconia were transferred into glass-bottom dishes and 
inspected by laser-scanning microscopy using a 405 nm laser.   Giant otoconia from 
Tg(-);Slc26a4∆/∆ mice were ~10-fold larger than normal otoconia (Figure 3.11D).  The 
shape of the giant otoconia resembled the shape previously observed in Slc26a4∆/∆ 
mice [101].  Otoconia in Tg(+);Slc26a4∆/∆ and Tg(+);Slc26a4∆/+ mice were similar 
consisting in both genotypes of larger (~20 µm, Figure 3.11E.1 and F.1) and smaller 
(~10 µm; Figure 3.11E.2 and F.2) otoconia, some of which revealed a concentric 
structure (Figure 3.11E.3 and F.3).  These data suggest that the introduction of the 
transgene rescued normal otoconia formation. 
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Figure 3.9: Hearing tests based on auditory brain stem responses.   
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A-C) Examples of recordings of auditory brain stem responses to tone bursts of 16 kHz at amplitudes 
between 0 and 90 dB-SPL that were presented to Tg(+);Slc26a4+/+ mice at P35 (A), Tg(-);Slc26a4∆/∆ mice 
at P35 (B),  and Tg(+);Slc26a4∆/∆ mice at P35 (C).  Thresholds at 15 dB-SPL are marked (thickened 
trace).  D-L) Hearing thresholds based on auditory brain stem responses, were determined in 
Tg(+);Slc26a4∆/+ mice (D-F), Tg(+);Slc26a4+/+ mice (G-I), and Tg(+);Slc26a4∆/∆ mice (J-L; highlighted in 
red).  Frequencies evaluated at 8 kHz (D, G, J), 16 kHz (E, H, K), and 32 kHz (F, I, L).  The combined 
ranges of normal hearing in the three mouse strains (129S6, C57BL/6 and CBA) that contributed to the 
background of the mice are marked (grey rectangles).  Numbers next to symbols in D-L represent the 
number of mice tested.  (Experiments conducted by JS) 
 
 
Balance 
Balance tests were performed in Tg(+);Slc26a4∆/∆ mice and Tg(+);Slc26a4∆/+ mice as 
well as in Tg(-);Slc26a4∆/+ and Tg(-);Slc26a4∆/∆ mice (Figure 3.12).  Tg(-);Slc26a4∆/∆ 
mice failed the test, which confirmed the vestibular phenotype previously described in 
Slc26a4∆/∆ mice [103].  There was no apparent difference in the performance of 
Tg(+);Slc26a4∆/∆, Tg(+);Slc26a4∆/+ and Tg(-);Slc26a4∆/+ mice.  These data demonstrate 
that the introduction of the transgene rescued normal gross motor vestibular function.   
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Figure 3.10: Histology and pendrin expression in the vestibular labyrinth.   
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Staining in all images consisted of immunocytochemistry of pendrin (Pds #1 antibody; red) and F-actin 
(green) and of nucleic acids (blue), the latter with the exception of images B and F.   Images provide 
comparison of cryosections (A, C-D) and whole-mounted specimens (B) from Tg(+);Slc26a4∆/∆ to 
cryosections (E, G-H) and whole-mounted specimens (F) from Tg(-);Slc26a4∆/+ mice.  Whole-mounted 
specimens were imaged by detecting fluorescence in 25 optical sections that were recorded in 1 µm 
intervals and projected into a single plane.  The number of pairs of mice represented by these images are 
2 for image A & E, 1 for B & F, 2 for C & G, and 2 for D & H with 3 sections being evaluated per animal.  
HC, vestibular hair cells; TC, transitional cells; M, melanocytes.  Additional images using an alternative 
anti-pendrin antibody (Pds #2) and alternative positive controls (Tg(+);Slc26a4∆/+ mice) are provided in 
the Supplement (Fig. 3.14).  (Experiments conducted by XL) 
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Figure 3.11: Otoconia.  
 A-C) Microdissected maculae utriculi from a Tg(-);Slc26a4∆/∆, Tg(+);Slc26a4∆/∆ and Tg(+);Slc26a4∆/+ mice.  
The macula utriculi have been marked (red dashed line) and a single otoconium is indicated (red arrow 
head).  D-F) Isolated otoconia from  Tg(-);Slc26a4∆/∆, Tg(+);Slc26a4∆/∆ and Tg(+);Slc26a4∆/+ mice.  Note 
that images D, E.1, E.2, F.1 and F.2 are presented at the same scale.  Mega-otoconia were found only in 
Tg(-);Slc26a4∆/∆ mice.  Tg(+);Slc26a4∆/∆ mice contained a mixture of larger and smaller otoconia, some of 
which showed a concentric pattern (E.1, E.2 and E.3) that was similar to the mixture found in Tg(-
);Slc26a4∆/+ mice (F.1, F.2 and F.3).  (Experiments conducted by XL and PW) 
74 
Discussion 
In this study we generated a mouse that expresses human pendrin in the endolymphatic 
sac but lacks detectable pendrin protein expression in the cochlea or in the vestibular 
labyrinth.  The most biologically interesting and clinically relevant observation of this 
study is that this mouse develops normal hearing and balance.  Our findings support the 
hypothesis that pendrin expression in the endolymphatic sac is chiefly responsible for 
the development of normal endolymph volume, that lack of pendrin in the endolymphatic 
sac is mainly responsible for the development of the membranous labyrinth 
enlargement in Slc26a4∆/∆ mice, and that the complex inner ear pathology found in 
Slc26a4∆/∆ mice is largely a consequence of the enlargement during embryonic 
development.   This hypothesis was based on the studies in Slc26a4∆/∆ mice that 
revealed that the enlargement is a key event on the path toward organ failure resulting 
in deafness and vestibular dysfunction [81,101,102] and on studies in Foxi1-/- mice that 
lack pendrin expression in the endolymphatic sac, develop an enlargement of the inner 
ear, but express pendrin in the cochlea and the vestibular labyrinth [123].  
 
Figure 3.12: Balance tests  
Tests were based on the ability of Tg(+);Slc26a4∆/+, Tg(+);Slc26a4∆/∆,  Tg(-);Slc26a4∆/+, Tg(-);Slc26a4∆/∆  
mice to balance on a rotating rod that was accelerated from 4 to 40 rpm over 60 s.  Numbers near the 
symbols indicate the number of mice evaluated.  (Experiments conducted by DH) 
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To test our hypothesis, we generated a transgenic mouse, Tg(B1-hPDS), which 
expresses human SLC26A4 (previously named PDS) controlled by the promoter of 
ATP1V1B1 [151].  The ability of the promoter of ATP1V1B1 to control gene expression 
had previously been evaluated in a transgenic mouse that expresses eGFP controlled 
by the promoter of ATP6V1B1 [149,152].  Expression of eGFP had been found in this 
mouse in intercalated cells of the renal collecting duct, and in narrow and clear cells of 
the epididymal epithelium of adult mice [149].  We found expression of eGFP in the 
embryonic kidney and in mitochondria-rich cells of the endolymphatic sac but not in the 
cochlea or the vestibular labyrinth (Figure 3.3).   Expression in mitochondria-rich cells of 
the endolymphatic sac was expected since these cells are members of the FORE family 
(forkhead related) of cells.  FORE cells express FOXI1, which drives the expression of 
Atp6v1b1 and Slc26a4 [39,88,90].  Consistently, mitochondria-rich cells of the 
endolymphatic sac express the mRNAs Atp6v1b1 and Slc26a4 [44,100] and the 
corresponding proteins, the B1-subunit of the vH+ATPase and pendrin [90,150].  The 
onset of expression of Atp6v1b1 in the endolymphatic sac is at E11.5, which is similar to 
the onset of pendrin [48,102].  Thus, it was likely that the transgene Tg(B1-hPDS) would 
drive a timely expression of pendrin in mitochondria-rich cells of the endolymphatic sac.    
 
Although FOXI1 drives the expression of Atp6v1b1 and Slc26a4 in FORE cells such as 
the mitochondria-rich cells of the endolymphatic sac, the expression of Atp6v1b1 and 
Slc26a4 is not limited to FORE cells. Indeed, Slc26a4 is expressed in the inner ear in 
spiral prominence and outer sulcus epithelial cells as well as in spindle-shaped cells of 
the cochlea and in transitional cells of the vestibular labyrinth, none of which are FORE 
cells [101,150].  Further, Atp6v1b1 expression has been found in the spiral limbus of the 
cochlea, which does not contain FORE cells [44,48]. The expression of Atp6v1b1 in the 
cochlea provided the possibility that the transgene would drive an ectopic expression of 
pendrin in the spiral limbus.  Our studies of eGFP expression (Figure 3.3) and of 
pendrin expression by Western blotting (Figure 3.4) and immunocytochemistry of whole-
mounted specimens and sections using two different anti-pendrin antibodies (Pds #1 
and Pds #2, Figure 3.7 and 3.13) revealed no detectable expression in the cochlea or 
vestibular labyrinth of Tg(+);Slc26a4∆/∆ mice.  The observed absence of pendrin 
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expression in the vestibular labyrinth of Tg(+);Slc26a4∆/∆ mice (Figure 3.10 and 3.14) is 
consistent with the reported lack of Atp6v1b1 expression in the vestibular labyrinth 
based on detection by in situ hybridization [44,48] and by quantitative RT-PCR (Figure 
3.2B and F), which is a more sensitive technique.  The observation that human 
SLC26A4 mRNA but no pendrin nor eGFP protein was detected in the cochlea or the 
vestibular labyrinth suggests the presence of strong translational regulation[153].  
Taken together, our data demonstrate that we have generated a mouse that expresses 
pendrin in the endolymphatic sac but not in the cochlea or the vestibular labyrinth, 
although we cannot completely rule out that low levels of pendrin protein expression 
escaped our detection.   Such low pendrin expression is unlikely the reason for the 
restored endolymphatic volume, since pendrin expression in the cochlea and vestibular 
labyrinth of Foxi-/- mice, which lack pendrin expression in the endolymphatic sac, did not 
prevent endolymphatic enlargement [123] and since mice that express a mutant pendrin 
protein that supports anion exchange at a reduced rate are deaf, develop mega-
otoconia and are balance impaired [105].  Moreover, hypomorphic mutant alleles of 
SLC26A4 show no difference in the resulting auditory phenotype from that of functional 
null alleles in patients with Pendred syndrome [126], indicating that small amounts of 
pendrin activity are insufficient to rescue hearing in humans. 
Measurements of the endocochlear potential and pH revealed that the introduction of 
the transgene, which rescued normal endolymph volume, also rescued the loss of the 
normal endocochlear potential and the loss of the normal endolymphatic pH 
homeostasis (Figure 3.8).  It appears that the Cl-/HCO3- exchanger pendrin, which is 
normally expressed in the apical membranes of spiral prominence and outer sulcus 
epithelial cells, is not the sole mechanism responsible for the alkaline pH of endolymph 
in a normally developed cochlea.  A similar conclusion can be drawn based on 
measurements in the doxycycline-inducible Slc26a4 mouse model where termination of 
pendrin expression at P6 led to the development of a nearly normal endocochlear 
potential and of a nearly normal alkaline pH [114].   We hypothesize that the epithelial 
barrier enclosing endolymph is permeable to H+, OH- and HCO3- and that the pH of 
endolymph follows the endocochlear potential.    
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Hearing and balance tests in Tg(+);Slc26a4∆/∆ mice revealed normal sensory function  
(Figure 3.9 and 3.12).  The observation that hearing thresholds at 32 kHz had some 
variability in Tg(+);Slc26a4∆/∆ mice and that some Tg(+);Slc26a4∆/∆ mice developed 
progressive high-frequency hearing loss is most likely a function of the genetic 
background.  Tg(+);Slc26a4∆/∆ were generated in a F2 generation from Slc26a4∆/∆ mice 
that were maintained isogenic in the 129S6 background and Tg(+);Slc26a4∆/∆ mice that 
were recently generated in a mixed background of C57BL/6 and CBA.  DNA from the 
three background strains, 129S6, C57BL/6 and CBA, which differ in their hearing 
thresholds, are expected to comprise variable amounts of the genomes of individual 
mice.  Hearing thresholds for 1 to 3 month-old 129S6, C57BL/6 and CBA mice range 
between 20-35 dB-SPL at 8 kHz, 10-28 dB-SPL at 16 kHz and 20-50 dB-SPL at 32 Hz 
[81,154–158].  In general, 129S6, C57BL/6 and CBA mice have similar thresholds at 8 
kHz, whereas at 16 and 32 kHz CBA mice have lower thresholds than 129S6 and 
C57BL/6 mice.  Thus, the greater variability in hearing thresholds that was observed at 
32 kHz particularly in Tg(+);Slc26a4∆/∆ may be due to a variability in the mixture of these 
background strains.   
Our observation that normal hearing developed in the absence of pendrin expression in 
the cochlea in combination with the published finding that normal hearing was 
maintained when pendrin expression was terminated after completed development 
[114], could suggest that pendrin in the cochlea has no physiologic significance beyond 
the developmental phase.  However, it is also conceivable that pendrin-mediated HCO3- 
secretion provides a buffer that stabilizes the pH in the lateral wall tissues as well as in 
endolymph, and that this buffering is important during stress situations associated with 
normal life.  Pendrin expression may indeed be important for the maintenance of 
hearing into advanced age.    
In summary, we demonstrated that restoration of pendrin to the endolymphatic sac is 
sufficient to restore normal inner ear function.  This implies that pendrin in the 
endolymphatic sac is more important for the development of normal hearing than 
pendrin expression in the cochlea and more important for the development of normal 
balance than pendrin expression in the vestibular labyrinth.  This finding, in conjunction 
with our previous report that pendrin expression is required for embryonic development 
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but not for the maintenance of hearing, opens the prospect that a spatially and 
temporally limited therapy will restore normal hearing in human patients carrying a 
variety of mutations of SLC26A4.  
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Figure 3.13 Histology and pendrin expression in the cochlea. 
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Staining in all images consisted of immunocytochemistry of pendrin (Pds #1 antibody or Pds #2 antibody; 
red), F-actin (green) and nucleic acids (blue). Images provide comparison of pendrin expression in 
Tg(+);Slc26a4Δ/Δ mice (A, C, E) to positive controls consisting of Tg(+);Slc26a4Δ/+ (B, D) or 
Tg(−);Slc26a4Δ/+ mice (F). Note that both antibodies, Pds #1 and Pds #2, failed to detect pendrin 
expression in Tg(+);Slc26a4Δ/Δ mice and that the staining pattern for pendrin in positive controls was 
similar for both antibodies and for both positive controls. The number of pairs of mice represented by 
these images are 2 for images A & B, 1 for C & D, and 2 for E & F with 3 sections being evaluated per 
animal. K, Kölliker's organ; OS, outer sulcus; Lim, spiral limbus; IS, inner sulcus; OC, organ of Corti; SP, 
spiral prominence; SV, stria vascularis; RM, Reissner's membrane. Compare these images to those in 
Figure 3.7.  (Experiments conducted by XL) 
 
 
Figure 3.14 Histology and pendrin expression in the vestibular labyrinth.  
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Staining in all images consisted of immunocytochemistry of pendrin (Pds #1 antibody or Pds #2 antibody; 
red) and F-actin (green) and of nucleic acids (blue). Images provide comparison of pendrin expression in 
Tg(+);Slc26a4Δ/Δ mice (A,C,E,G,I,K) to positive controls consisting of Tg(+);Slc26a4Δ/+ (B, F, J) or 
Tg(−);Slc26a4Δ/+ mice (D,H,L). Note that both antibodies, Pds #1 and Pds #2, failed to detect pendrin 
expression in Tg(+);Slc26a4Δ/Δ mice and that the staining pattern for pendrin in positive controls was 
similar for both antibodies and for both positive controls. The number of pairs of mice represented by 
these images are 2 for images A & B, 2 for images C & D, 1 for images E & F, 2 for images G & H, 2 for 
images I & J, and 2 for images K & L. HC, vestibular hair cells; TC, transitional cells; M, melanocytes. 
Compare these images to those in Figure 3.10 (Experiments conducted by XL) 
 
Methods 
Ethics Statement 
All animal experiments and procedures at Kansas State University were performed 
according to protocols approved by the Animal Care and Use Committees at Kansas 
State University (IACUC#: 2961).  All animal procedures at Sorbonne University Paris 
Cité were performed according to protocols approved by the ethics committee from 
University Pierre et Marie Curie, and were performed in accordance with the Guide for 
the Care and Use of Laboratory Animals (NIH publication No.93-23, revised 1985).   
 
Generation of Tg(B1-hPDS)Tg/+;Slc26a4+/+ transgenic mice  
Human SLC26A4 cDNA was ligated into a pBluescript vector that contained 6.9 kbp of 
the human ATP6V1B1 promoter [149,152].  An SV40 late region polyadenylation signal 
was cloned downstream of the SLC26A4 cDNA. The transgene Tg(B1-hPDS) included 
the 5'-flanking region of the ATP6V1B1 gene extending to but excluding the 
endogenous translational start codon, the human SLC26A4 cDNA, with its own 
translational start site, and the SV40 late region polyadenylation signal.  The integrity of 
the transgene was confirmed by restriction digest and bidirectional sequencing of 
ligation sites.  In preparation for injection, the transgene was linearized by SalI and NotI 
digestion, followed by gel purification using an electroelution method and then 
concentrated using ElutipD columns (Whatman). The transgene was then further 
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concentrated by ethanol precipitation and resuspended in low EDTA injection buffer (10 
mM Tris with 0.1 mM EDTA).  Tg(B1-hPDS) transgenic mice were created by the 
University of Utah transgenic mouse core facility using standard procedures [149,152].  
Genotyping revealed that 63 pups were positive for transgene integration.  One founder, 
which transmitted the transgene in a Mendelian fashion, was crossed with wild-type 
C57BL/6 x CBA F1 mice to establish a colony.  Three Tg(B1-hPDS);Slc26a4+/+ 
transgenic mice were shipped to Kansas State University in Manhattan, Kansas, USA.   
 
Generation of Tg(B1-hPDS)Tg/+;Slc26a4∆/∆ transgenic mice 
At Kansas State University, a colony of Tg(B1-hPDS)Tg/+;Slc26a4∆/∆ mice was 
established.  Colony management was supported by software (Litter tracker, written in 
Microsoft Visual Basic and Excel 2010 by P.W.)  Tg(B1-hPDS)Tg/+;Slc26a4+/+ mice were 
crossed with Slc26a4∆/∆ mice to generate Tg(B1-hPDS)Tg/+;Slc26a4∆/+ mice.  Matings of 
Tg(B1-hPDS)Tg/+;Slc26a4∆/+ mice generated 28 Tg(B1-hPDS)Tg/+;Slc26a4+/+, 58 Tg(B1-
hPDS)Tg/+;Slc26a4∆/+ and 39 Tg(B1-hPDS)Tg/+;Slc26a4∆/∆ mice in a near Mendelian ratio 
of 1 : 2 : 1 with a 75% rate of transmission for the transgene (based on 169 pups).    
 
Genotyping  
Mice were genotyped for Slc26a4+ and Slc26a4∆ alleles by PCR using established 
primers [103] and for the transgene Tg(B1-hPDS) (Transnetyx, Cordova, TN).   Primers 
for the transgene were designed to amplify a 345 bp PCR-product spanning the hPDS 
cDNA and the SV40 polyadenylation signal sequence (left primer: 5’-aga ggg tca agg ttc 
cat ttt ag-3’; right primer: 5’-caa acc aca act aga atg cag tg-3’) [148].   
 
Isolation of embryonic tissues 
Time-pregnant dams were deeply anesthetized with 4% tri-bromo-ethanol (0.014 ml/g 
body weight, i.p.) and embryos were harvested by laparotomy.  Dams and embryos 
were sacrificed by decapitation.  Gestational age was counted from the day when the 
vaginal plug was detected.  This day was set to embryonic (E) day 0.5.  Gestational age, 
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however, was verified by evaluating gross morphological features including limbs, digits 
and the appearance of the pinna and auditory meatus [159,160].   
 
Isolation of tissues from postnatal mice 
The age of mice was counted from the day of birth, which was set to postnatal (P) day 0.  
Postnatal mice were deeply anesthetized with 4% tri-bromo-ethanol (0.014 ml/g body 
weight, i.p.) and sacrificed by decapitation or cardiac perfusion with fixative.   
 
Quantitative RT-PCR 
Quantitative RT-PCR was performed on total RNA [116].  Total RNA was isolated from 
tissues obtained by microdissection from Tg(-);Slc26a4∆/+ and Tg(+);Slc26a4∆/∆ mice 
and subjected to quantitative RT-PCR using gene-specific primers for 18S rRNA as well 
as for mRNA coding for the α-subunit of the mouse Na+/K+ ATPase Atp1a1, the B1-
subunit of the mouse vH+ ATPase Atp6v1b1, mouse pendrin Slc26a4 and human 
pendrin SLC26A4, which was introduced via the transgene.   
Postnatal mice were genotyped by PCR prior to tissue collection.  Embryonic Tg(-
);Slc26a4∆/+ mice were generated by mating Tg(-);Slc26a4∆/∆ dams and Tg(-);Slc26a4+/+ 
sires, which yielded 100% of the desired genotype.  Embryonic Tg(+);Slc26a4∆/∆ mice 
were generated by mating Tg(+);Slc26a4∆/∆ dams and sires, which yielded 
Tg(+);Slc26a4∆/∆ and Tg(-);Slc26a4∆/∆ mice in a ratio of 3 : 1.  Since embryonic mice 
could not be genotyped prior to tissue collection, the desired Tg(+);Slc26a4∆/∆ mice 
among Tg(-);Slc26a4∆/∆ mice were initially identified by visual inspection of the size of 
the endolymphatic sac and the presence of ‘glittering’ otoconia, This phenotypic 
identification was subsequently confirmed by the presence of human pendrin SLC26A4 
transgene by RT-PCR.   
Tissues were obtained by microdissection.  Endolymphatic sacs (8-10 endolymphatic 
sacs from 4-5 animals per sample) were obtained from mice at age E17.5.  Cochlear 
ducts (4 cochlear ducts from 2 animals per sample and 2 cochlear ducts from 1 animal 
per sample) were obtained from mice at ages E17.5 and P2, respectively.  Vestibular 
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labyrinths (6 vestibular labyrinths from 3 animals per sample) were obtained from mice 
at age P8.  Total RNA was isolated from microdissected tissues (RNeasy micro kit, 
Qiagen, Valencia, CA, USA), treated with DNAse (RNeasy micro kit), combined with 
RNA storage solution (Applied Biosystems/Ambion, Austin, TX), adjusted to a 
concentration of 10 ng/µl, and stored at -80 C.    
Quantity and quality of total RNA were evaluated by microfluidic electrophoresis 
(BioAnalyzer, Agilent, Santa Clara, CA), by microliter absorption photometry (Nanodrop, 
Wilmington, DE) and by quantitative RT-PCR of 18S rRNA.  RNA samples were 
accepted for quantitative RT-PCR only when they were free of contamination and 
excellent RNA quality.  RNA quality was quantified by the RNA integrity number (RIN) 
on a scale from 0 (worst) to 10 (best) (BioAnalyzer, Agilent).  RIN numbers for total RNA 
isolated from E17.5 endolymphatic sac and cochlea were 8.2 ± 0.3 (n=3) and 9.2 ± 0.1 
(n=10).   
Chemicals were assembled with the assistance of an automatic pipetting station 
(Biomek NXp, Beckman Coulter, Fullerton, CA) with hardware modifications and 
software programming by P.W.  Quantitative RT-PCR reactions were carried out in 96-
well plates with each well containing ~10 ng of total RNA, gene specific primers, and an 
enzyme mix containing reverse transcriptase and DNA polymerase (iScript, BioRad, 
Hercules, CA) in a total volume of 25 µl.  Reverse transcription was performed for 10 
min at 50°C and terminated by heating to 95°C for 5 min (OneStepPlus, Applied 
Biosystems, Foster City, CA).  PCR consisted of 40 cycles of 10 s melting at 95°C, 30 s 
annealing and elongation at 58°C, and 15 s hot-measurement at 78°C (OneStepPlus, 
Applied Biosystems).   
Left and right primers (exon, product size) were for 18S 5’-gag gtt cga aga cga tca ga-3’ 
and 5’-tcg ctc cac caa cta aga ac-3’ (316 bp), for Atp1a1 5’-tgc ccg cct caa cat tcc-3’ 
(exon 14) and 5’-gac aca tca gag cca aca atc c-3’ (exon 16, 291 bp), for Atp6v1b1 5’-tga 
ccc gaa act aca tca cc-3’ (exon 1) and 5’-gcc aga gcc att gaa aat cc-3’ (exon 5, 305 bp), 
for mouse Slc26a4 5’-tct gat gga ggc aga gat ga-3’ (exon 20) and 5’-ggc cag cct aac 
aga gac ag-3’ (exon 21, 430 bp), and for human SLC26A4 were 5’-tcc caa agt gcc aat 
cca ta-3’ and 5’-aca tca agt tct tct tcc gtc ag-3’ (360 bp).  Primer pairs for Atp1a1, 
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Atp6v1b1, mouse Slc26a4 spanned introns to prevent amplification of genomic DNA.   
Primer pairs for mouse Slc26a4 detected the Slc26a4+ allele as well as the Slc26a4Δ 
allele that is lacking exon 8 [103].  Left and right primers for mouse Slc26a4 differed by 
7 and 10 nucleotides from the corresponding human sequence and left and right 
primers for human SLC26A4 differed in 4 and 6 nucleotides from the corresponding 
mouse sequence, thereby maximizing species-specific amplification.   Since the human 
transgene did not contain introns, some reactions were carried out without reverse 
transcriptase to determine whether products of SLC26A4 originated from cDNA rather 
than from genomic DNA.   These experiments revealed no evidence for significant 
amplification of genomic DNA.  Amplification of a single product of the appropriate size 
was verified by microfluidic electrophoresis (BioAnalyzer, Agilent).   
The number of template molecules (cDNATemplate) was estimated according to  
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where 6.02 x 1023 molecules/mol represents Avogadro’s number, ProductThreshold is the 
weight of the PCR-product at threshold (0.49 x 10-9 g) that was obtained from calibration 
experiments, ProductSize is the size of the product in base pairs (bp), Weightbp is 
average weight of one bp (660 g/mol), Efficiency is the PCR-efficiency obtained from 
the slope of the log-linear phase of the growth curve [134] and Ct is the cycle at which 
the fluorescence of the product molecules reaches a common threshold chosen in the 
middle of the log-linear part of the growth curve.   
 
Paint-fill 
Bisected heads of embryos age E15.5 were fixed overnight in Bodian’s fixative, 
contained (vol/vol) 75% ethanol, 5% acetic acid, and 5% formalin in water.  Heads were 
then dehydrated overnight in 100% ethanol and cleared in methyl-salicylate [161,162].  
The membranous labyrinth was injected via the lateral wall of the basal turn of the 
cochlea and via the endolymphatic sac with diluted paint (Liquid Paper, Newell 
Rubbermaid, Atlanta, GA, 0.1-0.2% in methyl-salicylate) using a fine glass-electrode, a 
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manipulator (NM-151 Narishige) and a micrometer-driven oil-filled microinjector 
(CellTram Vario, Eppendorf, Hamburg, Germany).  For each genotype, at least three 
inner ears were injected.   
 
Direct fluorescence of eGFP 
Whole mounts of fresh cochlear ducts, endolymphatic sacs and slices of kidney were 
prepared from E15.5 Tg(B1-eGFP) mice and visualized with a fluorescence microscope 
(AxioScope, Carl Zeiss Göttingen).   
 
Western blotting 
Crude membrane preparations of the inner ear: Soft tissues from 8 cochleae and 8 
vestibular labyrinths devoid of endolymphatic sacs from adult mice were collected by 
microdissection in Cl--free solution and pooled and homogenized in 500 µl Tris-sucrose 
buffer.  Cl--free solution contained (mM) 150 Na-gluconate, 1.6 K2HPO4, 0.4 KH2PO4, 4 
Ca-gluconate2, 1 MgSO4 and 5 glucose, pH 7.4.  Tris-sucrose buffer contained (mM) 
250 sucrose, 50 Tris-HCl, 5 EDTA, pH=7.4, and proteinase inhibitor cocktail (Cat# PI-
87786 Fisher, Pittsburgh, PA).  Homogenization involved a pestle/1.5 ml Eppendorf vial 
and a Potter-Elvehjem tissue grinder (3 strokes at 1,250 rpm; Cat# K885512-0020, 
Fisher).  Nuclei and debris were sedimented by centrifugation (6 min, 600g, 4°C, 
Micromax RF, International equipment, Needham Heights, MA) and the supernatant 
containing membranes was collected.  Pellets were washed 3x with 100 µl Tris-sucrose 
buffer.  Supernatants were pooled and membranes were pelleted by centrifugation (1 hr, 
21,000g, 4°C, Micromax RF).  Membranes were suspended in 30 µl Tris-sucrose buffer 
and protein content was quantified (BCA assay, Cat# 23227, Fisher; Absorption 
photometer, Nanodrop).   
Crude membrane preparations of kidneys: Kidneys (~1 g wet weight) were sliced, 
frozen in liquid N2, pulverized, transferred into 8 ml Tris-sucrose buffer and 
homogenized.  Homogenization involved pestles fitting 1.5 ml Eppendorf vials and the 
Potter-Elvehjem tissue grinder (3 strokes at 1,250 rpm).  Nuclei and debris were 
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sedimented by centrifugation (6 min, 600g, 4°C, Micromax RF) and the supernatant 
containing membranes was collected.  Pellets were washed 3x with 2 ml Tris-sucrose 
buffer.  Supernatants were pooled and membranes were pelleted by centrifugation (1 hr, 
21,000g, 4°C, Micromax RF).  Membranes were suspended in 200 µl Tris-sucrose 
buffer and protein content was quantified (BCA assay).     
Gel-electrophoresis, blotting and protein detection: Crude membranes were solubilized, 
denatured and reduced for 1 hr at 37 °C in LDS sample buffer (Cat#: NP0007; 
Invitrogen) supplemented with 50 mM DTT.  Proteins were resolved by gel-
electrophoresis (4-12% Bis-Tris gels (Cat#: NP0326, Invitrogen) using a MOPS-SDS 
running buffer supplemented with an antioxidant (Cat#: NP0005, Invitrogen) and 
transferred onto PVDF membranes (BioRad, 3 hrs at 30V).  PVDF membranes were 
blocked for 1 hr at RT in TBST solution containing 3% BSA.  TBST solution contained 
20 mM Tris-base, 68 mM NaCl, and 1% Tween-20.  Blocked PVDF membranes were 
incubated overnight at 4 °C with primary antibody in TBST solution with 3% BSA. 
Primary antibodies were a rabbit anti-pendrin antibody (Pds #2; 1:200) and a polyclonal 
rabbit anti-mouse β-actin antibody (1: 1,000; Cat#: A2066, Sigma-Aldrich).  Pds #2 was 
raised against the last 15 amino acids of the C-terminal of mouse pendrin [114].  Human 
pendrin differs in only 1 of these 15 amino acids.  PVDF membranes were washed 5 x 3 
min in TBST solution and then incubated for 1 hr at RT with the secondary antibody, 
goat anti-rabbit poly-HRP (Cat#: PI32260, Fisher) diluted in TBST solution with 3% BSA.  
The dilution of the secondary antibody was 1:2,500 for labeling the Pds #2 antibody and 
1:10,000 for labeling the β-actin antibody.  The membranes were washed 3 x 5 min in 
TBST solution.  HRP was detected by chemiluminescence (SuperSignal Femto, Cat# 
PI34095, Fisher).  The signal was integrated over 2-5 min by cooled CCD camera 
(ImageStation 4000R, Kodak).   
 
Immunocytochemistry 
Fixation: Isolated tissues from embryonic mice were fixed by submersion in PBS-
formaldehyde solution at 4 °C.  PBS-formaldehyde solution consisted of 4% 
formaldehyde (Electron Microscopy Sciences, Hatfield PA) in a solution that contained 
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(in mM) 137 NaCl, 2.7 KCl, 10.1 Na2HPO4, 1.8 KH2PO4.  Tissues from postnatal 
animals were fixed by cardiac perfusion followed by perilymphatic perfusion.   Cardiac 
perfusion was initiated with Cl--free solution (6 ml, 1 min) and followed by Cl--free 
solution with 4% formaldehyde (12 ml, 2 min).  Perilymphatic perfusion consisted of an 
infusion of Cl--free solution with 4% formaldehyde (25 µl, 5 min) through the round and 
oval window of the cochlea.   
Cryosections.   Fixed temporal bones were decalcified 18-24 h in 10% EDTA, 
processed through a sucrose gradient and infiltrated with polyethylene glycol.  Mid-
modiolar cryosections (12 μm, CM3050S, Leica, Nussloch, Germany) were blocked in 
PBS-TX (137 mM NaCl, 10.1 mM Na2HPO4, 1.8 mM KH2PO4, 2.7 mM KCl, pH 7.4 with 
0.15% Triton X 100) and 5% bovine serum albumin.  Slides were incubated overnight at 
4 °C with primary antibody in PBS-TX with 2.5% BSA.  Primary antibodies were two 
rabbit anti-pendrin antibodies (Pds #1; 1:200; a kind gift from Dr. Søren Nielsen, 
University of Aarhus, Denmark and Pds #2, 1:1,000) and a polyclonal FITC-conjugated 
goat anti-eGFP antibody (Cat#: GTX26662, GeneTex, San Antonio, TX).  Pds #1 was 
raised against the last 22 amino acids of the C-terminal of mouse pendrin.  Human 
pendrin differs in 6 of these 22 amino acids [102,163].  Slides were washed with PBS-
TX and, where appropriate, incubated for 1 h at RT with secondary antibody (1:1,000, 
goat anti-rabbit Alexa 594, Invitrogen, Carlsbad, CA).  After washing with PBS-TX, 
sections, where appropriate, were stained with phalloidin 488 (1:40; Invitrogen) to mark 
F-actin and DAPI (1:1,000; Invitrogen) to mark nuclei, washed again and cover-slipped 
with mounting medium (Vectashield HardSet Mounting Medium, Vector laboratories, 
Burlingame, CA).  
Whole-mounted specimens.  Tissues were obtained by microdissection from fixed 
temporal bones, washed in PBS-TX, and blocked with 5% bovine serum albumin in 
PBS-TX.  Tissues were incubated overnight at 4 °C with primary antibodies in PBS-TX 
with 2.5% BSA.  Primary antibodies were a rabbit anti-pendrin antibody (Pds #1; 1:200) 
or a polyclonal FITC-conjugated goat anti-eGFP antibody (GeneTex).  Slides were 
washed with PBS-TX and, where appropriate, incubated for 1 h at RT with secondary 
antibody (1:1,000, goat anti-rabbit Alexa 594, Invitrogen).  After washing with PBS-TX, 
tissues were stained with phalloidin 488 or phalloidin 594 (1:40; Invitrogen) and DAPI 
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(1:1000; Invitrogen), washed again and cover-slipped with mounting medium 
(VectaShield HardSet Mounting Medium, Vector laboratories, Burlingame, CA).  
Confocal microscopy.  Immunocytochemistry of cryosections and whole-mounted 
specimens were viewed by confocal microscopy (LSM 510 Meta, Carl Zeiss, Göttingen, 
Germany).  Laser scanning bright-field images were collected to aid orientation.    
 
Endocochlear potential and pH difference between endolymph and perilymph 
Mice were anesthetized with 4% tri-bromo-ethanol for in situ measurements of the 
endocochlear potential and pH with double-barreled microelectrodes.  Measurements 
were made in the basal turn of the cochlea by a round-window approach through the 
basilar membrane of the first turn of the cochlea [81,164].  The surgical cavity was 
covered with liquid Sylgard 184 (Dow Corning) to limit the loss of tissue CO2 into 
ambient air.   
Double-barreled glass microelectrodes were pulled (micropipette puller PD-5; Narishige) 
from filament-containing glass tubing (1B100F-4; World Precision Instruments) and 
baked at 180 ºC for 2 h to ensure dryness.  One barrel was silanized by a 30 s exposure 
to 0.008 ml dimethyldichlorosilane (40136; Fluka).  After silanization, microelectrodes 
were baked again at 180 ºC for 3 h and tips were broken to a final O.D. of ~3 μm.  The 
reference barrel was filled with 150 mM KCl and the ion-selective barrel was filled at the 
tip with liquid ion exchanger (Hydrogen ionophore II - Cocktail A, 95297; Fluka) and 
back-filled with buffer solution (500 mM KCl, 20 mM HEPES, pH 7.4).   
Each barrel of the double-barreled microelectrode was connected via a Ag/AgCl2 
electrode to an electrometer (FD223, World Precision Instruments).  A flowing KCl 
electrode (1 M KCl in 0.2% agar) was inserted under the skin of the animal to serve as 
ground electrode.  Data were recorded in analog (BD12E Flatbed recorder, Kipp & 
Zonen, Delft, The Netherlands) and digital form (DIGIDATA 1322A and AxoScope 10, 
Axon Instruments, Union City, CA).  pH electrodes were calibrated in situ at 37 ºC using 
three calibration solutions with different pH values.  Calibration solutions contained (in 
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mM):  pH 6: 130 NaCl, 20 MES; pH 7: 130 NaCl, 20 HEPES; and pH 8: 130 NaCl, 20 
HEPES.  pH-sensitive electrodes had a slope of 56.9  0.3 mV/pH unit (n=11).   
 
Hearing tests 
Mice were deeply anesthetized with a mixture of medetomidine and xylazine (0.375 
mg/Kg body weight medetomidine and 56 mg/kg body weight xylazine; i.p.) and placed 
on a thermal pad to maintain normal body temperature.  The mastoid, vertex and ventral 
neck region of the animal were connected via sub-dermal platinum needle electrodes 
(F-E2, Astro Med, Rhode Island, RI) and short (31 cm) leads to the main channel, 
reference channel and ground of the preamplifier, respectively.  Auditory brainstem 
recordings were performed in a custom constructed, electrically shielded and sound-
attenuated chamber (inner dimensions: 23 cm x 23 cm x 23 cm) using a digital data 
acquisition system (BioSig32 software, RA4LI Preamplifier, RP2.1 Enhanced Real Time 
Processor, PA5 Programmable Attenuator, ED1 Electrostatic Speaker Driver, Tucker-
Davis Technologies, Alachua, FL).  Tone burst stimuli were presented (21 per sec) via a 
free field electrostatic speaker (SigGen software, ES1 speaker, Tucker Davis).  Acoustic 
stimuli were calibrated using a 1/4 inch condenser microphone (SigCal IRP4.2 software, 
Tucker Davis, PS9200 microphone, Acoustical Interface, Belmont, CA) placed at the 
location of the mouse head.  Tone bursts (2 ms duration, 0.5 ms gate time; 8, 16 and 32 
kHz) were presented with alternating phase (0 and 180°).  Responses, recorded over 10 
ms, were filtered (300 Hz high pass, 3000 Hz low pass and 60 Hz notch) and 1000 
recordings were averaged.  Tone burst stimuli were presented at intensities varying 
between 90 and 0 dB SPL in 5 dB intervals.  Auditory thresholds were obtained by a 
visual comparison of wave forms.  After the procedure, mice were rapidly recovered 
from anesthesia with atipamizole (1.875 mg/kg body weight; i.p.).  
 
Balance tests 
Balance testing consisted of determining the time that mice could balance on a rotating 
1” rod with rotations ramping up from 4 to 40 rpm in 60 s (RotaRod, IITC Life Science, 
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Woodland Hills, CA).  Test chambers were cushioned with bubble-foil to provide a soft 
landing for mice falling off the rod.    
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Perspective 
To summarize the present study, we demonstrated that during the phase of cochlear 
growth and enlargement, the endolymph in cochlea and endolymphatic sac of 
Slc26a4Δ/+ and Slc26a4Δ/Δ mice is a NaCl-rich fluid that is subsequently modified into 
KCl-rich fluid shortly before birth.  The transition of ion composition from a NaCl-rich to a 
KCl-rich fluid likely results from transport by Na+/2Cl-/K+ cotransporter, SLC12A2, and 
the K+ channels, KCNQ1/E1.  These observations suggest that expansion of the 
endolymph volume stems from the failure to reabsorb NaCl.  Information gathered from 
our work on the mouse model expressing human pendrin specifically in the 
endolymphatic sac lead us to conclude that pendrin expression in endolymphatic sac is 
predominantly responsible for the development of a normal endolymphatic volume, as 
well as normal hearing and balance.   
The present findings raise more intriguing questions for future investigations: 1) What 
are the apparatuses and transporters responsible for fluid secretion and absorption? 
What is the mechanism for ion transport, such as Na+ and Cl-, in the mitochondria-rich 
cells and the principal cells of endolymphatic sac? Answering these questions will help 
identify potential pharmacological targets that could be manipulated to correct fluid 
transport, and subsequently prevent endolymph volume expansion. 2) What is the 
physiological role of pendrin in the cochlea and the vestibular labyrinth?  Does the lack 
of, or insufficient expression of pendrin in the cochlea increase the susceptibility for 
stress-induced hearing impairment? What is the compensatory mechanism for 
maintaining the acid-base status in the adult cochlear endolymph, when pendrin 
function is absent? Answering these questions would provide insights into the observed 
disease progression as well as provide potential treatments for EVA - related patients, 
who have fluctuated and progressive hearing loss in the adulthood. 
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